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Contribution of the Membrane-Proximal Region of the Vesicular Stomatitis Virus
Glycoprotein to Host Cell Entry and Membrane Fusion
Abstract
Vesicular stomatitis virus (VSV) is an enveloped, nonsegmented, negative-sense, RNA virus belonging to
the Rhabdoviridae family. VSV is considered the prototypic Rhabdovirus due to its simple genetic
organization, broad host cell tropism, and ability to be easily grown in cell culture. Therefore, VSV has
been used as the prototype to study viral entry, transcription, replication, and assembly. Viral entry, a
critical step in the lifecycle of the virus, is mediated by the outer surface protein, G and will be the focus of
this dissertation.
We hypothesize that the highly conserved residues in the membrane-proximal region of VSV G protein are
critical to membrane fusion through participation in low pH-induced conformational changes and stability
of theses structures. This hypothesis was tested initially through the use of site directed mutagenesis
and then by studying rapidly acquired second site mutations. Residues that are conserved completely or
conserved for their biochemical properties were either deleted or mutated to alanines. The mutated G
proteins were examined through the use of transient transfection assays for their surface expression
levels, fusion capacity, and ability to undergo pH dependent conformational changes. Mutation of a
conserved HPH motif (H423/P424/H425) resulted in a dramatic decrease in surface expression. ΔH423/
P424/H425 was completely fusion defective as assessed by syncytium formation assays that measured
cell-cell fusion. Likewise, the cell-cell fusion activity for ΔH425 was affected in that the pH threshold
required to trigger the fusion event was decreased. These findings support previous reports suggesting a
requirement for histidine protonation in order for the pH dependent conformational changes needed for
membrane fusion to occur. Recombinant viruses encoding the mutated G proteins were recovered and all
of the viruses expressing G proteins with reduced cell-cell fusion capacity, as compared to wild type, grew
to lower titers, with the exception of one mutant: D435A/D436A/E437A. Mutation of the DDE motif
resulted in a G protein with a reduced capacity to fuse in transiently transfected cells. However,
recombinant virus encoding D435A/D436A/E437A was recovered and unexpectedly grew to wild type
titers, suggesting that the virus is overcoming the fusion defect caused by the mutation. Wild type VSV
virions have been shown to express a truncated G protein on their surface, called G-stem (GS). GS was
detected on the virion of this mutant at levels higher than that of wild type suggesting the truncated G
protein was contributing to enhancing the infectivity of the virus.
Mutation of conserved phenylalanines (F440A/F441A) also resulted in a similar phenotype as the ΔH425
mutant. Reduced surface expression was observed when this mutated G protein was transiently
expressed in cells and a decrease in the threshold pH required for fusion was also observed.
Recombinant VSVs encoding the mutated G proteins were recovered to analyze the impact of the
mutations on the ability of the viruses to grow and spread. Interestingly, viruses encoding the ΔH425 and
the F440A/F441A mutant G proteins rapidly acquired additional mutations that made the viruses better
able to grow and spread as indicated by increased titers and plaque sizes. Plaque isolates were obtained
and subjected to sequence analysis revealing several variants: ΔH425/S438I, ΔHI426S/S438I, F440V/
F441A, F440T/F441A, F440A/F441A/S438I, and F440A/F441A/CT9. To identify the advantage the
additional mutations were providing the recombinant viruses (if any), the mutations were cloned into
expression vectors and the mutant G proteins were examined for their surface expression levels and
fusion capacity. The mutations appeared to enhance cell surface expression levels, with the exception of
the ΔH425/S438I and F440A/F441A/CT9 mutants. The F440A/F441A mutants still were reduced in cellcell fusion activity at pH 6.0 as compared to wild type G. However, the ΔH425 mutants’ fusion activity was
partially restored at pH 6.0. Results from these experiments suggest that when both the ΔH425 and
F440A/F441A mutant G acquire a S438I mutation the fusion capacity at pH 6.0 is restored. The findings

in these studies indicate residues in the membrane-proximal region of VSV G are critical to the fusion
process, suggesting a likely contribution to the stabilization of the pre- and postfusion structures.
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Abstract
Vesicular stomatitis virus (VSV) is an enveloped, nonsegmented, negative-sense,
RNA virus belonging to the Rhabdoviridae family. VSV is considered the prototypic
Rhabdovirus due to its simple genetic organization, broad host cell tropism, and ability to
be easily grown in cell culture. Therefore, VSV has been used as the prototype to study
viral entry, transcription, replication, and assembly. Viral entry, a critical step in the
lifecycle of the virus, is mediated by the outer surface protein, G and will be the focus of
this dissertation.
We hypothesize that the highly conserved residues in the membrane-proximal
region of VSV G protein are critical to membrane fusion through participation in low pHinduced conformational changes and stability of theses structures. This hypothesis was
tested initially through the use of site directed mutagenesis and then by studying rapidly
acquired second site mutations. Residues that are conserved completely or conserved for
their biochemical properties were either deleted or mutated to alanines. The mutated G
proteins were examined through the use of transient transfection assays for their surface
expression levels, fusion capacity, and ability to undergo pH dependent conformational
changes. Mutation of a conserved HPH motif (H423/P424/H425) resulted in a dramatic
decrease in surface expression. ΔH423/P424/H425 was completely fusion defective as
assessed by syncytium formation assays that measured cell-cell fusion. Likewise, the
cell-cell fusion activity for ΔH425 was affected in that the pH threshold required to
trigger the fusion event was decreased. These findings support previous reports
suggesting a requirement for histidine protonation in order for the pH dependent
conformational changes needed for membrane fusion to occur. Recombinant viruses
encoding the mutated G proteins were recovered and all of the viruses expressing G
proteins with reduced cell-cell fusion capacity, as compared to wild type, grew to lower
titers, with the exception of one mutant: D435A/D436A/E437A. Mutation of the DDE
motif resulted in a G protein with a reduced capacity to fuse in transiently transfected
cells. However, recombinant virus encoding D435A/D436A/E437A was recovered and
unexpectedly grew to wild type titers, suggesting that the virus is overcoming the fusion
defect caused by the mutation. Wild type VSV virions have been shown to express a
truncated G protein on their surface, called G-stem (GS). GS was detected on the virion
of this mutant at levels higher than that of wild type suggesting the truncated G protein
was contributing to enhancing the infectivity of the virus.
Mutation of conserved phenylalanines (F440A/F441A) also resulted in a similar
phenotype as the ΔH425 mutant. Reduced surface expression was observed when this
mutated G protein was transiently expressed in cells and a decrease in the threshold pH
required for fusion was also observed. Recombinant VSVs encoding the mutated G
proteins were recovered to analyze the impact of the mutations on the ability of the
viruses to grow and spread. Interestingly, viruses encoding the ΔH425 and the
F440A/F441A mutant G proteins rapidly acquired additional mutations that made the
viruses better able to grow and spread as indicated by increased titers and plaque sizes.
Plaque isolates were obtained and subjected to sequence analysis revealing several
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variants: ΔH425/S438I, ΔHI426S/S438I, F440V/F441A, F440T/F441A,
F440A/F441A/S438I, and F440A/F441A/CT9. To identify the advantage the additional
mutations were providing the recombinant viruses (if any), the mutations were cloned
into expression vectors and the mutant G proteins were examined for their surface
expression levels and fusion capacity. The mutations appeared to enhance cell surface
expression levels, with the exception of the ΔH425/S438I and F440A/F441A/CT9
mutants. The F440A/F441A mutants still were reduced in cell-cell fusion activity at pH
6.0 as compared to wild type G. However, the ΔH425 mutants’ fusion activity was
partially restored at pH 6.0. Results from these experiments suggest that when both the
ΔH425 and F440A/F441A mutant G acquire a S438I mutation the fusion capacity at pH
6.0 is restored. The findings in these studies indicate residues in the membrane-proximal
region of VSV G are critical to the fusion process, suggesting a likely contribution to the
stabilization of the pre- and postfusion structures.
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Chapter 1: Introduction
Enveloped Viruses: Host Cell Entry
Vesicular stomatitis virus (VSV) is an enveloped, nonsegmented, singlestranded, negative sense RNA virus in the Rhabdoviridae family. VSV serves as the
prototypic Rhabdovirus due to its broad host range, simple genetic organization, and
ability to be easily grown in cell culture. VSV has been used as a tool to better
understand various phases of enveloped viral life cycles. The focus of this work will
primarily be the role of the outer surface protein (G) in membrane fusion and viral entry.
In particular, the studies are aimed at examining the contribution of the membraneproximal region of G in virus-cell membrane fusion. All enveloped viruses must undergo
a fusion event with the host cell membrane for successful entry. Enveloped viruses have
evolved various mechanisms to achieve the common goals of membrane fusion and host
cell entry, as will be discussed further.
A Brief Introduction to Enveloped Viruses. Enveloped viruses are made up of a host
cell derived lipid membrane surrounding their nucleocapsid, with glycoproteins
embedded in this outer membrane. A common feature of all enveloped viruses is the
need for viral membrane fusion with a host cell membrane enabling the release of the
viral genetic information into the cell cytoplasm. Fusion is mediated by the glycoproteins
(or fusion proteins) protruding from the envelope of the virus. Viruses have evolved
many means by which to enter host cells to initiate cycles of replication to further spread.
Fusion can either take place between the outer membrane of the host cell or an endocytic
membrane (Smith and Helenius 2004; Earp, Delos et al. 2005). Fusion between the viral
membrane and a host membrane is either pH independent or pH dependent. Some
viruses, such as measles virus (Paramyxovirus), can bind and fuse at the cell surface,
while other viruses such as influenza virus and VSV hijack the host cell endocytic
pathway for entry into the cell (Helenius and Kartenbeck 1980; Matlin, Reggio et al.
1982). Fusion for viruses, such as VSV, that utilize the endocytic pathway is triggered
by the drop in pH in the endosome or processing by proteases that are active at low pH
within the endosome, while the viruses that fuse at the cell surface do not require a low
pH trigger, but instead rely on receptor or receptor/co-receptor recognition. Information
presented here will be focus mechanisms of enveloped virus entry mediated by viral
fusion proteins.
Viral Fusion Proteins. Envelope fusion proteins are responsible for receptor recognition,
host cell entry, and in some cases, play a role in egress from the host cell. Viral envelope
proteins have been widely studied in an effort to better elucidate the life cycle of
important human pathogens, such as influenza virus, HIV-1, and Ebola virus. Viral
fusion, as previously mentioned, is a process by which the viral membrane and a host
cell membrane are brought into close proximity, leading to lipid mixing, formation of a
fusion pore, and finally release of the viral genetic information into the host cell cytosol.
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Although viral fusion proteins vary widely in their structures and mechanisms of action, a
few common features are seen (Hernandez, Hoffman et al. 1996). Fusion proteins are all
similar in that they are type I transmembrane proteins which are made up of a large
ectodomain, a single transmembrane spanning domain, and a cytoplasmic tail. Other
commonalities include; they are all trimers and they all have a fusion peptide, which is a
short hydrophobic or non-polar sequence that is required for mediating fusion (White,
Delos et al. 2008). All fusion proteins undergo large conformational changes that drive
this process. These large scale changes in conformation provide the needed free energy
for mixing of two lipid bilayers, which is an energetically expensive event. In fusion
proteins studied thus far, the basic mechanism allowing for membrane mixing, resulting
in fusion pore formation and transfer of the nucleocapsid in to the cytosol, is through the
formation of a hairpin structure in the final conformation of the protien (Kielian and Rey
2006).
Fusion proteins have been divided in two well characterized groups (class I and
class II) (Lescar, Roussel et al. 2001) based on the structural features and transitions
leading to virus-host-cell fusion (Table 1-1). Some examples of viruses with class I
fusion proteins are Coronaviruses, Filoviruses, Arenaviruses, Orthomyxoviruses,
Paramyxoviruses, and Retroviruses (Skehel and Wiley 1998; Eckert and Kim 2001;
White, Delos et al. 2008). Influenza virus HA is the prototypic class I fusion protein,
while the fusion proteins from Alphaviruses and Flaviviruses make up class II fusion
proteins. Recent structural determination of the glycoprotein (G) from vesicular
stomatitis virus (Roche, Bressanelli et al. 2006; Roche, Rey et al. 2007) and one of the
fusion proteins from herpes simplex virus, gB, (Heldwein, Lou et al. 2006) has led to the
identification of class III fusion proteins. The next section will discuss the similarities
and differences in the three classes of fusion proteins by describing prototypic members
of each.
Three Classes of Viral Fusion Proteins
Class I Viral Fusion Proteins. Class I viral fusion proteins all share common structural
and functional characteristics in their fusion mechanisms. One key feature common to
the class I viral fusion proteins is a refolding event that occurs during the fusion process.
In the prefusion state, class I fusion proteins are present as trimeric spikes on the virion
surface. Proteolytic cleavage is required for these proteins to mature to the prefusion
form. Cleavage of the envelope protein can occur in the low pH environment of the
endosome, or during maturation of the protein. Triggering of fusion leads to the
rearrangement of a highly stable rod-like structure with a central α-helical coiled-coil,
which is termed the pre-hairpin intermediate. A key feature among this class of viral
fusion proteins is the positioning of the fusion peptide, which is initially buried in the
trimer interface. Initial triggering of fusion allows for formation of the pre-hairpin
intermediate which exposes the fusion peptide and allows for insertion of the fusion
peptide into the target membrane. While in this intermediate conformation the protein is
in an extended form in which the C-terminal transmembrane domain and the fusion
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Table 1-1. Characteristics of class I and class II fusion proteins.
Class I Features

Class II Features

Conformational change from a
metastable trimer to a stable trimer
during fusion

Conformational change and
oligomeric rearrangement from a
metastable dimer to a stable
trimer

Secondary structure is primarily
α-helical

Secondary structure is
predominantly β-sheet

Post fusion structure is a trimer of
hairpins with a central α-helical
coiled-coil (6-helix bundle)

Post fusion structure is a trimer
of hairpins primarily made up of
β-sheets

Proteolytic processing of fusion
protein required to mature to the
pre-fusion state

Proteolytic processing of a
companion protein required for
maturation to the pre-fusion state

In the metastable pre-fusion state
the fusion peptide is N-terminal
and buried in the trimer interface

In the metastable pre-fusion state
the fusion peptide is located at
the fusion protein tip and is
capped by dimer interaction
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peptide are at the opposite ends of the molecule. The next step in the conformational
change is the formation of a hairpin structure in which the C-terminal transmembrane
domain and the fusion loops are brought into close proximity. Formation of the hairpin
structure pulls the viral and host cell membranes together for the fusion event to occur.
Some class I viral fusion proteins include: the S2 protein from SARS; the HA protein of
the influenza A and B viruses; the F1 protein from PIV-5; and gp41 from HIV-1. The
first viral fusion protein to be extensively studied was that of Influenza virus (HA)
(Wiley, Wilson et al. 1981; Wilson, Skehel et al. 1981). From these studies began the
understanding of a general pathway that enables membrane fusion. I will next discuss the
means by which Influenza virus HA protein mediates membrane fusion to serve as an
example of a typical class I protein.
Influenza Virus HA. Influenza virus belongs to the Orthomyxoviridae family and is a
segmented, negative strand, enveloped, RNA virus. Embedded in the envelope are three
types of surface protein, NA, HA, and M2. HA has both receptor binding and fusion
activity, both of which are necessary for entry of influenza into host cells.
Initially HA0 protein is synthesized as uncleaved monomers that must fold
correctly and trimerize for proper trafficking through the secretory pathway to the cell
surface (Gething, McCammon et al. 1986). HA0 is a trimer with a large globular head
domain that is made up primarily of two subunits, HA1 and a long α-helical coiled-coil
stalk region (Chen, Ariel et al. 1988). Host cell proteases cleave the precursor protein
HA0 into two disulfide bonded subunits, HA1 and HA2. After cleavage, the overall
structure of HA is nearly unchanged except the N-terminal fusion peptide becomes buried
in the trimer interface within the α-helical stalk. HA1 binds the receptor and is present on
the virion surface in a metastable state, while HA2 is the transmembrane subunit (also in
a metastable state) that contains the fusion peptide and is required for membrane fusion.
HA1 binds sialic acid-containing receptors on the host cell surface (Wiley and
Skehel 1987). The virion is internalized into the host cell through endocytosis as is
observed in VSV infection (Maeda and Ohnishi 1980; Huang, Rott et al. 1981; White,
Matlin et al. 1981). As the pH drops in the endosome to around 5 or 6 (Daniels, Downie
et al. 1985), HA undergoes an irreversible conformational change from the prefusion
metastable state to a low pH conformation (Bullough, Hughson et al. 1994) (Fig 1A).
This irreversible conformational change contrasts with the reversible change observed in
the VSV G fusion protein.
First, HA1 trimer contacts at the head domains are dissociated with the low pH
induced conformational change. This initial conformational change releases the fusion
peptide from its buried position and projects it toward the target membrane, where it
irreversibly inserts (Bullough, Hughson et al. 1994). At this stage the protein is anchored
in the target membrane by the fusion peptide and anchored in the virion membrane by the
transmembrane domain, thereby forming the pre-hairpin intermediate. The next step in
the conformational change is the movement of the long α-helix of HA2 folding
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A

Cell Membrane

Virus Membrane

B

Cell Membrane

Virus Membrane
Figure 1-1. Class I and class II mediated fusion schematic. (A) A schematic
representing HA mediated membrane fusion (class I). HA protein (prior to cleavage) is
present as trimers on the virion surface. Large conformational change occurs after
exposure to low pH exposing the fusion peptide leading to insertion into the target
membrane. The fusion protein folds back on itself forming the six helix bundle and
pulling the two membranes together for membrane merger (Skehel and Wiley 2000). (B)
A Schematic representing class II mediated membrane fusion, as shown by SFV E. SFV
E1 (yellow) and E2 (purple) are initially present on the virion surface as dimers.
Exposure to low pH causes dissociation and exposure of the fusion loop. Low pH and
presence of cholesterol in the target membrane triggers insertion of the fusion loop and
alignment of the E1 subunits, favoring trimerization. E1 folds back on itself pulling the
two membranes together leading to initial lipid mixing (hemifusion), which then
progresses to full fusion. (Kielian and Rey 2006).
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downward, reversing the direction of the membrane proximal segment of HA2, in effect
pulling the two opposing membranes together (Bullough, Hughson et al. 1994). The
postfusion conformation of HA2 is a highly stable rod with the transmembrane domain
and the N-terminal fusion peptide at the same end of the molecule forming a trimer of
hairpins (also referred to as a six-helix bundle)(Eckert and Kim 2001). Membrane fusion
in class I viral fusion proteins is driven by the energy that is released during the
conformational changes from the metastable, prefusion form to the stable post fusion
form (Ruigrok, Wrigley et al. 1986; Carr, Chaudhry et al. 1997; Melikyan, Markosyan et
al. 2000; Russell, Jardetzky et al. 2001). Structural analysis of other fusion proteins
revealed unique features from what was seen in Influenza virus HA protein, which led to
the grouping of a second class of fusion protein, that will now be discussed.
Class II Viral Fusion Proteins. Class II fusion proteins differ in several ways from their
class I counterparts. Viral glycoproteins in the Alphavirus and Flavivirus families are
initially present on the virion surface as dimers. Although the ectodomains of these
proteins do not share much sequence homology, their secondary and tertiary structures
are very similar (Lescar, Roussel et al. 2001). Secondary structures of class II fusion
proteins are primarily made up of β-sheets (Kielian and Rey 2006; White, Delos et al.
2008). Classs II fusion proteins differ from class I fusion proteins in that they require a
regulatory protein to fold properly that is later cleaved by the cellular protease, furin, late
in the secretory pathway. This cleavage is a critical regulatory step for viral entry
(Wengler and Wengler 1989; Salminen, Wahlberg et al. 1992; Stadler, Allison et al.
1997; Zhang, Wang et al. 2003). After cleavage of the regulatory protein, class II fusion
proteins undergo an oligomeric rearrangement in which the dimers dissociate and
reorganize into trimers, a process triggered by low pH in the endosome (Wahlberg, Bron
et al. 1992; Allison, Schalich et al. 1995). When the dimers dissociate, the fusion
peptide becomes exposed and inserts into the target membrane. A key difference
between class I and class II fusion proteins is the location of their fusion peptide. Class II
fusion proteins have an internal fusion peptide while the class I fusion proteins have a
fusion peptide that is located N-terminally. The presence of cholesterol in the target
membrane is needed for insertion of the fusion peptide into the target membrane in
Alphaviruses (Kielian, Keranen et al. 1984; Nieva, Bron et al. 1994) and enhances
membrane insertion in Flaviviruses (Corver, Ortiz et al. 2000; Stiasny, Koessl et al.
2003) as shown by liposome experiments. Insertion of the fusion peptide lines up the
fusion proteins in a manner such that trimerization is favored. The protein then folds
back on itself positioning the transmembrane domain and the fusion loops near one
another and pulling the two membranes together. Semliki Forest virus E1 protein is a
well characterized example of a class II fusion protein that will be described in further
detail.
Semliki Forest Virus E1 Mediated Fusion. Semliki Forest virus (SFV) is a small,
enveloped, positive strand RNA virus whose fusion is mediated by E1 glycoprotein
embedded in the viral membrane. E1 is organized into three domains with the major
secondary structure being β-sheets, a key feature of class II fusion proteins (Lescar,
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Roussel et al. 2001; Roussel, Lescar et al. 2006). Domain I (DI) begins at the N-terminus
of E1 and has one end connected to two long extensions in Domain II (DII) with the other
end is connected to domain III (DIII) by a linker region. One extension is the fusion loop
while the other extension is the ij loop, which is closely associated with the fusion loop at
the DII tip. Domain III connects to the stem region, which leads to the transmembrane
domain, and contains an immunoglobin-like fold (Gibbons, Reilly et al. 2004).
An interesting feature of SFV E1 is that it actually lies tangential to the virus
membrane in its native state (Fig 1-1B). E1 is present as a heterodimer in a complex with
E2, the receptor binding subunit, at the virion surface. Initially, the fusion peptide is
hidden by E2 when in the complex. As the pH drops in the endosome, a conformational
change in the E1/E2 heterodimer occurs, causing dissociation of the complex, which in
turn exposes the fusion peptide (Fig 1-1B). The next step in the process leading to fusion
of the virus membrane with the endosomal membrane is the insertion of the fusion loop
into the target membrane. Insertion of the fusion loop is dependent upon the presence of
cholesterol in the target membrane (Kielian, Keranen et al. 1984; Nieva, Bron et al.
1994). Once the fusion loop interacts with the target membrane the E1 monomers are
aligned and reorganized into trimers. Once the monomers have formed trimers they fold
back on themselves forming a hairpin. Formation of the hairpin structure is dependent
upon domain III and the stem region folding back on the fusion loop. The stem region
has been shown to be important to E1 mediated virus-membrane fusion (Liao and Kielian
2006), which will be discussed at greater length later in this chapter. Vesicular stomatitis
virus G does not completely fit into either of these previously characterized classes of
fusion proteins and therefore, a third class of fusion proteins will be discussed.
Class III Viral Fusion Proteins. Fusion glycoproteins from the Rhabdovirus and
Herpesvirus families do not fit into either class I or class II fusion proteins. A key
characteristic that separates class I and class II fusion proteins is the location of the fusion
peptide. Class I fusion proteins have an N-terminal fusion peptide, whereas the fusion
peptide in class II fusion proteins is internal. Class III fusion proteins appear to have
qualities seen in both classes of viral fusion proteins. One commonality between these
fusion glycoproteins and those from class I and II is the use of conformational changes to
drive the formation of a hairpin oligomeric structure to pull the two opposing membranes
together. Class III glycoproteins are initially present as trimers and remain trimers after
the conformational change during virus-cell fusion, which is seen in class I fusion
proteins. Like class II fusion proteins, these proteins have β-sheets as their major
secondary structure, however, they also have α-helices as seen in class I fusion proteins.
Class III fusion proteins also have internal fusion loops like class II. It is not known if
Rhabdoviruses and Herpesviruses fit into one class alone or if they vary widely enough
from one another that they cannot be classified together. One possibility is that the less
well characterized mechanisms for fusion in these proteins all essentially function in the
same manner. However, viruses such as Herpesviruses and Poxviruses use a number of
viral glycoproteins to fuse with target membranes. This complexity indicates that there
may be much about the fusion processes that has yet to be determined. Vesicular
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stomatitis virus is the prototypic Rhabdovirus and serves as a good model to study fusion
mechanisms of viruses in which less structural information is available.
Vesicular Stomatitis Virus. Vesicular stomatitis virus (VSV) is a prototypic member of
the Vesiculovirus genus and Rhabdoviridae family. VSV is a small, enveloped virus with
a single molecule of negative sense RNA as its genetic material. The virion has a bullet
shaped morphology typical to Rhabdoviruses, and is approximately 180 nm long and 75
nm wide. VSV has been used as a prototypic virus to study entry, replication, and
assembly due to its simple genetic organization, ability to be easily grown in cell culture,
and broad host cell tropism. While VSV does not normally infect humans, the virus
infects livestock and farm animals causing vesicular lesions on the hooves, teats, and
gums. Vesicular stomatitis viruses are classified into two major serotypes: New Jersey
and Indiana. These two serotypes share approximately 50% glycoprotein amino acid
sequence homology (Rose and Whitt 2001). Other serotypes of VSV include
Chandipura, Cocal, Piry, and Isfahan. VSV’s antisense, 11Kb genome encodes five
major proteins; the nucleocapsid (N), phosphoprotein (P), matrix (M), glycoprotein (G),
and large polymerase (L). In addition to the 5 structural proteins, C and C’ are
synthesized from an alternative reading frame in the P mRNA (Spiropoulou and Nichol
1993). Two other proteins (M2 and M3) are N-terminal truncation mutants (Jayakar and
Whitt 2002).
The focus of this dissertation is the entry of VSV, which is initiated by the
binding of the envelope protein, G, to an unknown host cellular receptor. Identification
of the receptor for VSV G has been challenging due to the broad cell tropism of the virus.
Initial studies using proteolytic digestion of the cell surface did not inhibit VSV infection,
indicating the receptor is not likely a protein. Furthermore, the receptor was shown to be
soluble in chloroform-methanol and was sensitive to phospholipase C, indicating the
binding activity involves phospholipids (Schlegel, Willingham et al. 1982). Incubation
of VSV with purified phosphatidyl serine resulted in an 80-90% decrease in VSV plaque
formation (Schlegel, Willingham et al. 1982). The authors concluded the host cell
receptor was likely phosphatidylserine (PS). Other reports suggested that VSV binding
to cells is mediated by electrostatic interactions (Carneiro, Bianconi et al. 2002). The
most recent findings, published in 2004, claim that the experiments indicating
phosphatidyl serine is the receptor for VSV could not be reproduced. Experiments in this
report indicated the level of PS on the cell surface had no affect on VSV infection or
binding to cells. Furthermore, when cells were incubated with annexin V, which
specifically binds PS on the cell surface, VSV binding and infection was still detected.
Addition of PS to the cells enhanced VSV infection, but was not necessary, indicating PS
is not the receptor but may be important to a step in the entry pathway post binding (Coil
and Miller 2004).
Following cellular receptor binding, VSV is internalized into clathrin-coated
endosomes (Matlin, Reggio et al. 1982). Fusion of the virus envelope with the
endosomal membrane occurs as the pH drops to around 6.2 to 6.3 (the threshold pH for
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fusion of VSV G). Once fusion occurs, the nucleocapsid containing the VSV genome is
released into the cytoplasm where replication occurs.
Approximately 1200 molecules of G are present on the virion surface, and these
are organized into 400 trimeric spikes (Thomas, Newcomb et al. 1985). G is a typical
type I transmembrane protein that is embedded into the viral envelope with a short
cytoplasmic tail of 28 to 29 amino acids, a 20 residue transmembrane domain, and a large
antigenic ectodomain of 446 amino acids (Rose, Welch et al. 1980; Rose, Doolittle et al.
1982). The VSV virion is made up of two components, the ribonucleoprotein (RNP)
core, and the membrane envelope. The ribonucleoprotein core contains a single copy of
the negative-sense RNA genome encapsidated in a tight complex with about 1,200
molecules of the nucleocapsid protein (N). The L (large catalytic subunit) and P
(phosphoprotein) proteins make up the RNA-dependent RNA polymerase which is also
associated with the RNP. The L and P proteins are present in about 50 and 500
molecules, respectively in the virion (Thomas, Newcomb et al. 1985). The M protein
must be removed for uncoating of the viral genome. This protein also plays a role in
assembly of progeny virions as well as budding from the host cell membrane.
Approximately 1800 molecules of matrix protein are inside the viral envelope between
the membrane and the nucleocapsid core. Although this work focuses on the entry of
VSV a brief discussion of VSV replication will follow to give a complete description of
the viral life cycle.
Replication of VSV. Viral replication of VSV occurs entirely in the host cell cytoplasm
following entry. The viral genome is released into the cytoplasm and undergoes
uncoating (Rigaut, Birk et al. 1991; Lyles and McKenzie 1998). Uncoating is a process
by which the M protein dissociates from the RNPs causing decondensation of the RNP
cores. Recent studies in our lab support a model in which the uncoating process is
coupled to virion membrane fusion with the endosomal membrane. When the pH drops
in the early endosome, VSV G undergoes a conformational change which mediates
fusion. At this time, G also mediates the acidification of the virion interior which is
suggested to affect the interaction between the membrane bound and the RNP bound M,
leading to the release of the RNP into the host cell cytosol for replication (Mire 2008).
The encapsidated RNA genome then is used as a template for the RNA-dependent RNA
polymerase mediated transcription. Transcription is initiated at the 3’ end of the genome
and is sequential and polar as with other nonsegmented negative-sense RNA viruses.
Each of the five genes is transcribed in the order in which is appears from the 3’ end of
the gene (Iverson and Rose 1981; Iverson and Rose 1982; Lyles and McKenzie 1998).
These viral mRNAs then serve as templates for the synthesis of the viral proteins. The
viral mRNAs are capped, methylated and polyadenylated by the RNA polymerase
(Schubert, Keene et al. 1980; Hercyk, Horikami et al. 1988). Once enough N protein is
made the leader is encapsidated. Replication of the viral genome then ensues, allowing
for synthesis of the full-length positive sense replicative intermediate (RI). The RI is
encapsidated and serves as a template for the synthesis of the genome. The newly made
genomic RNA is encapsidated by the N protein to form the RNP. N protein is thought to
associate with G protein in the plasma membrane. The M protein is recruited to the
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budding site leading to association with the nucleocapsid (Lyles and Swinteck 2008).
The cores then bud through the host cell plasma membrane with the G proteins embedded
within, forming new progeny virions. Further rounds of infection then ensue with the
binding of the G protein to the next host cell, internalization, and fusion. The next few
sections will focus more specifically on the G protein of VSV.
Vesicular Stomatitis Virus Glycoprotein. G protein is synthesized on the rER, is
transported to the cell surface via the secretory pathway, and is localized to the host cell
membrane. The glycoprotein is synthesized as a 511 amino acid precursor with a 16
amino acid signal peptide that is cleaved during transport into the ER. G has widely been
used to study protein folding and protein transport through the secretory pathway,
therefore much is known about its folding and maturation process (Doms, Keller et al.
1987; de Silva, Balch et al. 1990; de Silva, Braakman et al. 1993). While in the ER, the
glycoprotein of VSV Indiana receives two N-linked oligosaccharides at positions 179 and
336. The G protein of the Indiana serotype is palmitoylated at a cysteine residue in the
cytoplasmic tail, but this modification has been shown not to impact function of the
protein (Whitt, Buonocore et al. 1991). As G is being translated, the ectodomain of G
associates with ER chaperones, BiP (Machamer, Doms et al. 1990) and calnexin
(Mathieu, Grigera et al. 1996). This association helps in proper folding and formation of
disulfides in the ER. Once the G protein monomers are properly folded, they form noncovalently associated homotrimers. Formation of homotrimers is essential for the
exocytic transport of G (Doms, Keller et al. 1987; Doms, Ruusala et al. 1988).
Interestingly, VSV G trimers have a unique quality in that they are unstable and there is
constant dissociation and reassociation of monomers that occurs both in the ER and on
the cell surface (Zagouras, Ruusala et al. 1991; Zagouras and Rose 1993). Soluble forms
of G, lacking the transmembrane and C-tails were constructed and were able to form
trimers when expressed in cells, indicating the region responsible for trimerization lies
within the ectodomain (Crise, Ruusala et al. 1989). Trimerization of VSV G has been
proposed to be stabilized by the M protein (Lyles, McKenzie et al. 1992) as shown by
incubating purified M protein or M protein associated with nucleocapsid protein with G
and using resonance energy transfer to detect association of subunits. Since all fusion
proteins in their active form have trimeric quaternary structure, it stands to reason that
stabilization of VSV G trimers is critical to the productive entry of the virus. VSV entry,
as mentioned above, is the focus of this work, so the next sections will address various
aspects of membrane fusion and viral entry.
pH Dependent Conformational Changes. One limitation to the full understanding of the
fusion process previously has been the fact that no structural information was available
for G. VSV G adopts at least three different conformational states of which two of these
structures have recently been published (Roche, Bressanelli et al. 2006; Roche, Rey et al.
2007) (Fig 1-2A and B). One unique feature of VSV G is the reversible nature of the pH
dependent conformational changes. There is a pH dependent equilibrium between the
pre- and post fusion conformations that is shifted toward the postfusion conformation
when exposed to low pH (Roche and Gaudin 2002). In both class I and class II mediated
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Figure 1-2. Crystal structures of VSV G. (A) Crystal structure of VSV G in its
prefuison state. G sits on the virion surface like a tripod with the fusion loops shown in
green (located in the fusion domain, yellow) extending toward the virion. Domain I, in
red, is the lateral domain. Domain II (blue) on the interior is the trimerization domain.
Orange represents the pleckstrin homology (PH) domain, III. Reprinted with permission
from Roche, S., F. A. Rey, et al. (2007). "Structure of the prefusion form of the vesicular
stomatitis virus glycoprotein G." Science 315(5813): 843-848. (B) G in its post fusion
form is represented using the same color scheme to identify each domain. All the
domains undergo dramatic change in their orientation and position but retain their
original folds except domain III which refolds. Reprinted with permission from Roche,
S., S. Bressanelli. et al. (2006). "Crystal structure of the low-pH form of the vesicular
stomatitis virus glycoprotein G." Science 313(5784): 187-191.
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fusion, the glycoproteins are in a metastable state initially and upon the fusion trigger
undergo irreversible conformational changes to a more stable form. The prefusion
structure of VSV G is made up of four distinct domains (Roche, Rey et al. 2007).
Domain I is referred to as the lateral domain, while domain II is the trimerization domain
that likely functions to supply the interactions needed to form G trimers. Domain III is
called the pleckstrin homology domain (PH) and may likely serve for host cell binding
due to the PH domain’s capability to bind phosphoinositides (Harlan, Hajduk et al. 1994;
Bottomley, Salim et al. 1998; Rebecchi and Scarlata 1998; Lemmon and Ferguson 2000).
Domain IV is the fusion domain, containing the fusion loops that are required for
membrane fusion and consequently, host cell entry.
Membrane proteins are difficult to crystallize due to their amphiphillic character
and the fact that they must be kept soluble by detergents throughout the entire
purification and crystallization process. Therefore, to avoid this dilemma, the G protein
was cleaved with thermolysin generating a truncated G in which the membrane proximal
region was not included. The focus of the work described in this dissertation is to better
understand the role of the membrane proximal region of G protein in host cell entry.
Since no structural data exists, theses studies employed a mutagenesis approach to
examine the contribution of this region to the fusion process. In the prefusion
conformation, G sits on the viral membrane in the shape of a tripod with the C-terminal
segment extending out from the viral membrane (in a manner that is yet unknown). The
fusion loops are kept apart and serve as the legs of the tripod.
Class I and class II fusion proteins are different in that their hydrophobic
segments are buried at an oligomeric interface in the prefusion conformation while the
fusion loops of G are exposed. Once exposed to low pH a dramatic structural
rearrangement occurs. Within the lateral domain and the trimerization domain is a rigid
block (RbI-II) that remains constant between pre- and postfusion conformations. In the
transition between the prefusion conformation to the postfusion conformation, the fusion
domain and the C-terminal segment flip relative to the RBI-II. Both fusion loops and the
transmembrane (TM) domain move ~160Å from one end of the molecule to the other.
Domains I, III, and IV retain their folded structure during this dramatic reorganization of
the protein. Proposed intermediates in the structural transitions position the fusion loops
in proximity to the target membrane in which they are able to insert. The final step in the
conformational changes after the insertion of the fusion loops is the formation of the
trimer of hairpins in which the two opposing membranes are brought into close proximity
allowing for full fusion.
As mentioned previously, G is unique in that the conformational changes are
reversible. The crystal structure of the low pH conformation was solved through P408,
with a histidine at position 407. Based on the crystal structures the authors suggested that
H407 participates in a salt-bridge with D137, in the fusion domain, that likely stabilizes
the post fusion structure (Roche, Bressanelli et al. 2006). Although the structures of G in
the prefusion and low pH conformations have provided a wealth of information as to the
fusion mechanism, many questions still remain. Intermediates in the conformational
changes have yet to be identified and also the membrane-proximal region is not included
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in any structures, thereby leaving gaps in the understanding of the participation of this
region. Studies of other membrane-proximal regions of fusion proteins have given
insight as to an overall possible mechanism of action, but since VSV differs in the
structural transitions from the better understood class I and class II fusion proteins further
work must be done to understand the role of the membrane-proximal region. As
mentioned, the crystal structure revealed a histidine residue that is likely important for
stabilization of the post fusion structure. Histidine protonation has been suggested to be a
key step in pH dependent viral fusion as will be discussed further.
Role of Histidine Protonation in pH Dependent Conformational Changes. Although
VSV G differs in the structural transitions seen with class I and class II fusion proteins,
one commonality is the requirement of a fusion trigger. Some viruses within each group
of fusion proteins require exposure to low pH for host cell entry. Interestingly, low pH
induced fusion generally occurs at a pH close to the pKa of histidine in water (pKa = 6),
strongly suggesting the protonation of one or more residues may drive the conformational
changes. As mentioned above, the crystal structure reveals H407 likely participates in a
salt bridge with D137 further supporting this hypothesis. Studies have indicated that
protonation of histidines in other viral fusion proteins may drive the pH dependent
conformational changes. Analysis of sequences from Influenza virus and Flavivirus
envelope proteins, respectively, revealed a number of highly conserved histidine residues
(Kampmann, Mueller et al. 2006). When histidines are buried within the protein, a lower
pH is required for protonation, which could account for lower pH requirements for fusion
proteins such as seen in dengue virus (pH for fusion is 5) (Heinz and Kunz 2004). Most
recently, Margaret Kielian’s group identified a histidine residue (H3) in Semliki Forest
virus that is required for the structural transitions that lead to fusion (Qin, Zheng et al.
2009). Five histidine residues were mutated to alanines with the one mutation at residue
3 resulting in reduced growth and a decrease in the pH required for membrane fusion.
Dissociation of the heterodimer was not affected but the formation of E1 homotrimers
required a decrease in pH from that of wild type. Speculation as to the role of histidines
in the low pH induced conformational changes seen in VSV G arose well before the
crystal structures were solved. In fact, chemical modification of histidines in G abolished
cell-cell fusion. When the chemical treatment was reversed, VSV G mediated fusion was
restored (Carneiro, Stauffer et al. 2003). Together these findings strongly suggest that
the protonation of one or more histidine residues drives low pH induced conformational
changes required for VSV G mediated membrane fusion. The next sections will
specifically focus on membrane-proximal regions of viral fusion proteins and the possible
contribution of this region in the G protein to membrane fusion.
Membrane-Proximal Regions of Viral Fusion Proteins
The membrane-proximal segments of various viral fusion proteins have highly
hydrophobic characteristics and are often rich in tryptophan residues. In the final post
fusion conformation, the membrane-proximal regions of viral fusion proteins are in close
proximity with both membranes as well as in a position to possibly interact with the
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fusion domains (or fusion loops). Reports have suggested the membrane-proximal
regions of HIV-1 gp41, (Salzwedel, West et al. 1999), Semliki Forest virus E1 (Liao and
Kielian 2006), and VSV G (Jeetendra, Robison et al. 2002; Jeetendra, Ghosh et al. 2003),
may have a mechanistic role in membrane fusion (virus entry).
HIV-1 gp41 Mediated Fusion. To understand the contribution of the membrane
proximal region (MPER) of Human immunodeficiency virus (HIV-1), I will first provide
a general overview of the fusion mechanism. HIV-1 is an enveloped virus in the family
Retroviridae, genus Lentivirus, whose host cell entry mechanism has been widely
studied. Protruding from the virion envelope are glycoprotein spikes termed env. HIV
env is initially synthesized as a fusion inactive protein called gp160. gp160 is cleaved
during transport to the cell surface while in the trans-Golgi complex into a non-covalently
linked heterodimer made up of gp120 and gp41(Hallenberger, Bosch et al. 1992;
Decroly, Vandenbranden et al. 1994). Gp120 is the receptor binding portion of the
protein, while gp41 is the transmembrane segment containing the fusion peptide and is
necessary for virus-cell fusion (Wyatt and Sodroski 1998). Gp41 is made up of three
main domains, the ectodomain, membrane spanning domain, and the cytoplasmic tail.
Within the ectodomain are the fusion peptide and two heptad repeats, one at the Nterminus and one at the C-terminus, and the membrane-proximal external region
(MPER). The MPER is a tryptophan rich region located N-terminally to the
transmembrane domain (Salzwedel, West et al. 1999).
HIV-1 binds to a target cell via gp120 by utilizing a CD4 receptor (Maddon,
Dalgleish et al. 1986) and a chemokine co-receptor (Lapham, Ouyang et al. 1996; Trkola,
Dragic et al. 1996; Wu, Myszka et al. 1996; Berger 1998). Unlike Influenza HA, Semliki
forest virus E, and VSV G, HIV env mediated fusion until recently has been believed to
be pH independent (Stein, Gowda et al. 1987; Maddon, McDougal et al. 1988; McClure,
Marsh et al. 1988). Recent evidence supports another model of entry in which HIV-1
enters via receptor mediated endocytosis and fuses within the endosome with the help of
the cellular protein, dynamin (Miyauchi, Kim et al. 2009). This report indicated that only
lipid mixing occurred at the plasma membrane whereas productive entry occurred via the
endocytic pathway. Furthermore, due to the low levels of HIV-1 env on the virion
surface (Zhu, Liu et al. 2006) it stands to reason the virus may need the additional help of
cellular proteins to overcome the energy barrier leading to the membrane merger event.
However, this model still indicates the need for the receptor/co-receptor binding. This
initial receptor and co-receptor binding leads to a dramatic conformational change that
exposes the V3 loop of gp120 (Choe, Farzan et al. 1996; Wu, Myszka et al. 1996). The
initial conformational changes allow the glycoptrotein to interact with the chemokine coreceptor. Final conformational changes are triggered by binding to the co-receptor
leading to virus-cell fusion (reviewed in Berger, Murphy et al. 1999; Doms and Trono
2000). These final conformational changes involve heptad repeats within the fusion
protein reorganizing to form a six-helix bundle (hairpin structure). The conformational
changes result in the hairpin formation that is seen in viral fusion proteins in their post
fusion conformation. Like the other proteins described thus far, the TM domain and the
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fusion peptide lie at the same end of the molecule pulling the two membranes together
(Chan, Fass et al. 1997; Weissenhorn, Dessen et al. 1997).
HIV-1 gp41 MPER. The membrane proximal external region (MPER) of gp41 has been
shown to play a critical role in efficient incorporation into the viral envelope, as well as
infectivity of HIV-1 (Salzwedel, West et al. 1999). The MPER has been predicted
though computer algorithms to form α-helices and also overlaps at the C-terminal
sequence of a peptide, DP-178, that has been shown to potentially inhibit fusion and virus
entry by binding to a portion of the N-terminal heptad repeats (Wild, Dubay et al. 1994).
An epitope for a neutralizing antibody, 2F5, also lies within this region of the fusion
protein. Five tryptophan residues are found within this short hydrophobic sequence that
are conserved among all sequenced strains of HIV-1, and make up more than 25% of this
region. Site-directed mutagenesis was used to determine the importance of these residues
for maturation and virus entry. When seventeen residues in this region were deleted, cellcell fusion was abolished, while maturation of the protein, transport, and binding of CD4
were not affected. Substitution of all five tryptophans with alanines also resulted in the
same phenotype. Single mutations were made to the tryptophan residues resulting in
inefficient incorporation and decreased infectivity (Salzwedel, West et al. 1999).
The indole ring in tryptophan residues has been shown to have a strong tendency
to insert into the membrane-water interface where it disrupts the organization of the
phospholipids (Reithmeier 1995). Interestingly, this region can be replaced by a foreign,
tryptophan rich sequence without significant fusion loss. These results indicate
tryptophan residues are key factors in the fusion process. The work described here, from
Eric Hunter’s lab, supports the hypothesis that the membrane proximal region of HIV-1
gp41 utilizes the conserved tryptophans to interact with the target membrane at some
stage during fusion to allow for fusion pore formation and transfer of viral genetic
information.
Paramyxovirus F Stem. The stem region of Paramyxovirus fusion proteins have been
shown to participate in the fusion process by a similar mechanism as was just described
for HIV-1 gp41. Paramyxoviruses are enveloped, negative-stranded, RNA viruses.
Paramyxovirus entry involves two surface proteins, an attachment protein (HN, H, or G)
and a fusion protein (F). Viral entry for these viruses occurs at the host cell plasma
membrane when the attachment protein binds the receptor, activating the F protein for
membrane fusion (Russell, Jardetzky et al. 2001; Takimoto, Taylor et al. 2002; Corey,
Mirza et al. 2003; Gravel and Morrison 2003; Porotto, Murrell et al. 2005). F protein is
initially synthesized as a precursor protein F0 and is cleaved into a small amino terminal
subunit, F2, and a carboxy-terminal subunit that is larger, F1. F protein has two heptad
repeat regions (termed HRA and HRB) that are both located in the ectodomain of F1.
HRA is located N-terminally (adjacent to the fusion peptide) while HRB is located
adjacent to the transmembrane domain. Studies using peptides directed toward either
HRA or HRB revealed an inhibition in membrane fusion activity of F protein and
replication of virus. The finding that the HRB region (stem region) of the F1 protein is
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important to the formation of the hairpin structure (Russell, Jardetzky et al. 2001) is of
particular interest, since the work presented here will be focused on the contribution of
the membrane-proximal region of VSV G.
Semliki Forest Virus E1 Stem. Another glycoprotein that has been shown to have a
membrane-proximal region that plays a key role in fusion is that of the SFV E1 protein.
As mentioned previously, SFV E is grouped into the class II fusion proteins. SFV E is
cleaved, forming E1, E2, and E3, with E1 containing the fusion peptide. E1 upon
exposure to low pH reorganizes to form trimers as the fusion domain is inserted into the
target membrane. The trimers undergo further conformational changes leading to the
formation of the final hairpin structure. As with other viral glycoproteins, little is known
about the structure or function of the stem region due to difficulties in crystallizing this
region of a membrane protein. However, work has been done using site directed
antibodies to this region providing some insight as to the role the memrane-proximal
region might play may play (Liao and Kielian 2006). Polyclonal antibodies were made to
either the N-or C-terminal halves of the E1 stem and used to identify intermediate
conformational changes by blocking regions that may interact during the conformational
changes. Data has shown that, unlike HIV-1 gp41 MPER, the stem region in E1 is
thought to play a role in the conformational changes leading to the formation of the final
trimer of hairpins (Liao and Kielian 2006). A critical step in the formation of hairpins
and fusion process is packing of the outer layer of the protein onto the cental core. It was
found that the stem was hidden in the neutral pH conformation and became exposed with
the initial pH induced conformational changes. The stem then appeared to pack onto the
trimer core to further the hairpin formation and at this point was once again inaccessible
to antibody binding. These data suggested that the membrane-proximal region is
important in mediating the fusion process, however is not absolutely necessary (Liao and
Kielian 2006; Liao and Kielian 2006). The roles of the membrane-proximal regions of
these fusion proteins provide clues as to the possible contribution of the region in VSV G,
the focus of this work.
VSV G Stem. Since no structural information on the membrane-proximal stem region of
G exists due to the need for thermolysin cleavage, the role this region plays in fusion has
been challenging to understand. The carboxy terminus of G has been show to have a high
degree of sequence homology between vesiculoviruses (Masters, Bhella et al. 1989;
Gaudin, Raux et al. 1996; Jeetendra, Ghosh et al. 2003). Among the highly conserved
residues in the stem region are completely conserved tryptophans. Substitution analysis
of these tryptophan residues revealed that, unlike HIV-1 gp41, they are not necessary for
fusion or budding from the host cell (Jeetendra, Ghosh et al. 2003). However, the
membrane-proximal region of G has been shown to enhance the efficiency of VSV
budding. Previous studies have shown that VSV can bud in the absence of G, however
producing about 50-fold less particles (Schnell, Johnson et al. 1997). Truncation of G so
that only the C-terminal and transmembrane domains were present indicated further
requirements for efficient budding, suggesting a role within the ectodomain of G
(Robison and Whitt 2000). Another truncation mutant (that will be discussed further in
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the context of fusion), containing the C-tail, TM domain, and 42 membrane proximal
amino acids was able to drive near wild type levels of viral budding (Robison and Whitt
2000). Further mutational analysis was done by making large insertions or deletions
within the stem region to identify the impact on membrane fusion or virus infectivity.
Deletion of the 13 membrane-proximal residues reduced cell-cell fusion and decreased
virus infectivity by approximately 100-fold (Jeetendra, Ghosh et al. 2003). Insertions
and deletions in the membrane-proximal region showed a decrease in fusion activity as
well as virus infectivity indicating this region plays a role in membrane fusion (Jeetendra,
Ghosh et al. 2003).
Initial evidence indicating a possible role for the membrane-proximal region of
VSV G was the development of a truncation mutant, as mentioned above, of G containing
the C-tail, transmembrane domain, and 42 residues leading up to the transmembrane
domain (Robison and Whitt 2000). This mutant was constructed based on a temperature
sensitive mutant, ts045. ts045 produces VSV particles lacking the G protein (“bald”)
when grown at the restricted temperature, 39.5°C (Knipe, Baltimore et al. 1977;
Zilberstein, Snider et al. 1980). At this temperature G is misfolded and is retained in the
endoplasmic reticulum and therefore no G protein can be detected on the surface. These
results were used for a long time to show that G protein was not necessary for the
assembly and budding of the virus. It was later shown that the “bald” virus particles
produced by ts045 actually had a short portion of the G protein containing a part of the
membrane proximal ectodomain, the transmembrane domain, and the cytoplasmic tail
(Metsikko and Simons 1986). Robison and Whitt then constructed GS to determine if
this short region of the ectodomain influenced assembly and budding of VSV. They
showed that GS is expressed, forms trimers, is incorporated into the viral envelope with
high efficiency and can promote wild type levels of budding (Robison and Whitt 2000).
Therefore, this short region of the ectodomain was shown to contain signals for efficient
budding. This mutant has also been studied in the context of viral fusion to further
understand the role of the membrane-proximal region. This mutant has been found to
potentiate the fusion activity of other heterologous viral glycoproteins that do not
normally fuse on their own (Robison and Whitt 2000; Jeetendra, Robison et al. 2002).
GS not only potentiates the fusion activity of glycoproteins that fuse at low pH, but also
those that fuse at neutral pH. This finding indicates that GS participates in a step in the
fusion process that is common to both pathways. Furthermore, GS has the ability to
induce an active hemifusion state, an indication that GS can interact with and perturb
membranes (Jeetendra, Robison et al. 2002).
Thesis Statement
Recent determination of VSV G crystal structures in the prefusion and low pH
forms has provided a wealth of information on the fusion mechanism of VSV G. Not
only has it helped in identifying possible structural transitions that mediate the fusion
process, but it has identified another way to achieve cell-virus membrane fusion.
Previously, viral fusion proteins were grouped into two classes based on their oligomeric
structure, their predominant secondary structure, the location of the fusion peptide and

18

the presence of a companion protein. Fusion proteins in each of these groups have
similar structural rearrangements leading to virus-cell membrane fusion. Structural
determination of VSV G and HSV gB has led to the classification of a third group of viral
fusion proteins that may induce membrane fusion through an alternative pathway to
achieve the fusion active conformation. One caveat to the recent developments in
understanding VSV G mediated fusion is the lack of structural information for the
membrane proximal region adjacent to the transmembrane domain. One key feature seen
in all fusion proteins thus far examined is the formation of a trimer of hairpins that
functions to pull the two opposing membranes together leading to the membrane merger
and fusion. Members of class I fusion proteins, such as HIV-1 gp41 and Influenza HA
proteins require the membrane proximal region either for the formation of the hairpin or
for the membrane merger event. Evidence has also shown the stem region in class II
fusion proteins, such as Semliki Forest virus E1, plays a role in fusion. Previous
mutational analysis has indicated the requirement for the highly conserved membrane
proximal region in VSV G mediated fusion. Studies have shown that large insertions and
deletions affect membrane fusion and virus infectivity, while mutation of the conserved
tryptophan residues does not appear to have a marked effect. The work presented here is
aimed to determine if individual residues in this highly conserved region play a direct
role in the fusion process and to better understand the contribution of the membrane
proximal region in VSV G mediated membrane fusion. We hypothesize that the highly
conserved residues in the membrane-proximal region of VSV G protein are critical to
membrane fusion through participation in low pH induced conformational changes and
stability of theses structures. In Chapter 3, I will examine the importance of the highly
conserved residues in the stem region of G in fusion by using site-directed mutagenesis.
In Chapter 4, I will examine second-site mutations that restored fusion activity in the
context of the virus to determine the significance of these mutations in surface expression
and viral fusion. The results from Chapters 3 and 4 will give insight as to residues that
may directly participate in the fusion process to better formulate a model for VSV G
mediated fusion and perhaps contribute further to the understanding of how the
membrane-proximal regions of other viral fusion proteins participate in the fusion
process.
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Chapter 2: Materials and Methods
Mutagenesis
Plasmids and Oligonucleotide-Directed Mutagenesis. The mutated G protein constructs
were generated using overlapping PCR with pVSV-9.1(+) (Lawson, Stillman et al. 1995)
as the template. The sequences of the primers used in generating the mutated G proteins
are listed in Table 2-1. The PCR products were generated using conditions as follows;
95°C denaturation for 2 minutes, thirty cycles of amplification with 45 seconds at 95°C,
45 seconds annealing at 50°C, then 72°C for 1 minute, followed by one cycle of
incubation at 72°C for 7 minutes. The PCR products were purified on a 6%
polyacrylamide gel and electroeluted. The fragments were digested using KpnI and NheI
restriction enzymes. The fragments encoding mutated G protein were subcloned into the
pCAGGS-GInd expression vector previously digested with the same enzymes. Colonies
were selected and DNA was extracted using an alkaline lysis mini-prep protocol. The
DNA was sequenced in both directions using pC-5’MCS
(TACAGCTCCTGGGCAACGTG) and pC-3’MCS (TAGCCAGAAGTCAGATGCTC).
Sequencing was performed by the Molecular Resource Center at the University of
Tennessee Health Science Center. The mutated G fragment from the pCAGGS
expression vector was then subcloned into the full length VSV genome, pVSV-9.1 (+)
(Lawson et al 1995), using KpnI and NheI.
For the F440/F441 mutants that acquired additional mutations, BHK-21 cells
were infected at an MOI = 1 for 1 hour while rocking at 31°C. The inoculum was
removed and replaced with fresh Dulbecco’s Modified Eagles Medium (DMEM)
containing 5% Fetal Bovine Serum (FBS). 6 hours post infection, RNA extraction was
performed on the cells. 1 mL of Trizol was added to the cells while rocking at room
temperature for 5 mins to lyse the cells and the lysates were transferred to 1.5 ml
eppendorf tubes. 0.2 ml of chloroform was added, tubes were shaken for 15 seconds and
incubated at room temperature for 3 minutes. The samples were centrifuged at 10,000 g
for 15 minutes, the aqueous phase was collected and transferred to a new tube. RNA was
precipitated by adding 0.5 ml of isopropanol and the samples were incubated at room
temperature for 10 minutes. The samples were pelleted by centrifugation at 10,000 g for
10 mins and the supernatant removed. The pellet was rinsed with 75% ethanol and
vortexed. The pellet was air dried and resuspended in 25 µl of nuclease free water.
Reverse transcription (RT) was performed on the 2 µg of RNA extracted from the
infected cells using a One-step RT-PCR kit from Quiagen according to manufacturer’s
instructions. Primers that were used for the RT and PCR amplification were MW36
(coding) and 3464 (non-coding) (Table 2-1). cDNA was digested with NheI and KpnI
restriction enzymes and subcloned into a pCAGGS-GIND expression vector digested with
the same enzymes. Plasmids were sequenced to identify any additional mutations in the
G gene containing the originally cloned in substitutions or deletions.
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Table 2-1. Sequences of primers used in overlapping PCR mutagenesis.
Mutation

Sense Primer

Antisense Primer

ΔH423/P424/H425

5’GCTCAGGTGTTCGAAA
TTCAAGACGCTGCTTCG3’

5’GTCTTGAATTTCGA
ACACCTGAGCCTTTG 3’

H423A/P424A/H425A

5’AGGTGTTCGAAGCTGCTG
CAATTCAAGACGCTGCTT 3’

5’GTCTTGAATTACAGC
AGCTTCGAACACCTG
AGCCTTTG 3’

ΔH425

5’GTGTTCGAACCTCACATT
CAAGACGC 3’

5’GAATGTGAGGTTCGA
ACACCTGAGC 3’

H425A

5’AGGTGTTCGAAGCTCCT
CACATTC 3’

5’GTCTTGAATGTGAGG
AGCTTCGAA 3’

D435A/D436A/E437A

5’CTTCTTGCTGCTGC
TAGTTTATTTTTTGG 3’

5’ATAAACTAGCAGCA
GCAGGAAGTTGC 3’

F440A/F441A

5’GAGAGTTTAGCTGCTG
GTGATACTGGGC 3’

5’TATCACCAGCAGCTA
AACTCTCAT 3’

T444A/G445A

5’GGTGATGCTGCTCTA
TCCAAAAATCC 3’

5’TTGGATAGAGCAG
CATCACCAAAAAATA
AACTCTC 3’

N449A/P450A

5’CTATCCAAAGCGGCGA
TCGAGCTTGTAGAAGG 3’

5’CTACAAGCTCGATCG
CCGCTTTGGATAGCCCA
GTAT 3’

MW36
(Outside Primer)

5’GTGGATCTCAGCTATCT
TGCTCC 3’

3464
(Outside Primer)

5’CAAACATGAAGAA
TCTGGCTAGCA 3’

21

Surface Expression. Surface expression of the various G proteins was initially measured
using indirect immunofluorescence assays. Approximately 7.5 x 105 baby hamster
kidney cells (BHK-21) were transfected with a DNA:liposome suspension containing
2µg of plasmid encoding the respective G mutants and 8µl of lipofectamine (GIBCOBRL), according to the manufacturer’s instructions. Three hours post transfection, the
media was replaced with DMEM containing 10% FBS and the cells were incubated for
24 hours at 37°C.
Following transfection and expression as described above, the cells were fixed
with 3% paraformaldehyde and processed for indirect immunofluorescence microscopy.
The cells were probed with a G specific monoclonal antibody, Mab I1 (Lefrancois and
Lyles 1982), followed by a secondary anti-mouse antibody conjugated to FITC (Jackson
ImmunoResearch Laboratories, Inc.). The cells were transfected as previously described
using 2µg of plasmid DNA and 8µl of Lipofectamine reagent (GIBCO) according to
manufacturer instructions. The transfection media was removed and replaced DMEM
containing 10% FBS and the cells were incubated at 37°C for approximately 24 hours.
The cells were removed from the plates using PBS containing 50 mM EDTA and pelleted
by centrifugation at 1250 x g for 5 min. The cells were fixed in suspension for 10
minutes in 3% paraformaldehyde at room temperature. Two washes were done using
PBS containing 10 mM glycine + 0.05% sodium azide to quench the fixative, then the
suspension was incubated in PBS-glycine + 0.5% bovine serum albumin (BSA) (Sigmaaldrich) for 30 minutes at room temperature. The cells were then probed with a
monoclonal antibody directed toward G, I1, followed by a secondary goat anit-mouse
antibody conjugated to FITC. To quantify cell surface expression, flow cytometric
analysis was employed. The cells were analyzed by flow cytometry using an LSRII
Special Option Flow Cytometer (BD). BHK-21 cells transfected with empty vector
(pCAGGS-MCS) were used as a negative control and cells expressing wild type G were
used as the positive control.
Surface expression was also examined in virally infected cells. BHK-21 cells
were plated out to ~90% confluency and infected with the appropriate virus at an MOI=1
for one hour while rocking at 31°C. The inoculum was then replaced with DMEM
supplemented with 5% FBS and the cells transferred to a 37°C incubator with ~ 7% CO2.
Six hours post infection cells were removed from the dish as described above, fixed and
stained with I1 followed by FITC secondary antibody for flow cytometric analysis.
Initial Characterization of Mutants
Cell-Cell Fusion Assays. BHK-21 cells were transiently transfected as described above
and approximately 24 hrs post transfection the cells were treated with fusion media
[(10mM Na2HPO4, 10mM N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid
(HEPES), 10mM 2-(N-morpholino) ethanesulfonic acid (MES) titrated to the indicated
pH (e.g. 5.2, 5.5, 6.0, 7.0)] by rinsing one time with fusion media at the appropriate pH,
then incubating for 1 min at room temperature. The fusion media was then replaced with
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DMEM containing 5% FBS and incubated at 37°C for 30 minutes. The cells were not
fixed in order to allow for better visualization of polykaryon formation and then
photographed using phase contrast optics with a 10X objective on a Zeiss Axiophot
camera and Axiophot software. Fusion was then quantitated by counting the cells not
fused in three separate fields of view, and averaging them. Percent of cells fused was then
determined by subtracting the average number of unfused cells from the average number
of cells in the plates treated with buffer at neutral pH (unfused). The number of mutant
unfused cells was then divided by the number of fused cells and multiplied by 100.
Alternately, BHK-21 cells were infected at an MOI=1 for 1 hour while rocking at
31°C. The inoculum was removed and replaced with DMEM containing 5% FBS and
incubated at 37°C for 6 hours. At 6 hours post infection, the cells were treated with
fusion medium as described above then fixed with 3% paraformaldehyde. Fusion was
then measured as described.
Metabolic Labeling, Transport Kinetics, and Trypsin-Sensitivity Assays. The assays
were done as previously described (Fredericksen and Whitt 1995; Fredericksen and Whitt
1995) with a few modifications. BHK-21 cells were plated out into 35mm plates at
~80% confluency and transfected with 2µg of the appropriate plasmid as described
previously. Approximately 12 hours post transfection, the cells were rinsed once in
methionine free DMEM (met-free) and then incubated in 2mls met-free DMEM for 15
minutes at 37°C. The media was replaced with 2mls of met-free DMEM containing
50µCi of [35S] methionine (protein labeling mix, Perkin-Elmer) for various amounts of
time. The cells were then either lysed immediately with 1 ml of detergent lysis buffer
(10mM Tris, (pH 7.4), 66mM EDTA, 1% TX-100, 0.4% deoxycholic acid, 0.02% sodium
azide) or chased with DMEM + 5% FBS medium containing 2mM excess nonradioactive methionine and then lysed at the desired times. The cell lysates were
centrifuged at 14,000 rpm for 1 min on a table-top microcentrifuge to remove the nuclei
and cell debris. Anti-G tail rabbit polyclonal antibody (#3226) was then used as the
primary antibody for immunoprecipitation as previously described (Whitt, Buonocore et
al. 1991) except that the post-nuclear supernatants were made to 0.3% sodium dodecyl
sulfate (SDS) and the primary antibody incubations were performed at 37°C for 1 hour.
For transport kinetic studies, one half of the cell lysates were digested with Endo H (New
England Biolabs) according to the manufacturer’s instructions. Samples were then
subject to analysis on a 10% SDS-PAGE gel.
The trypsin-sensitivity assay was performed by labeling BHK-21 cells expressing
G protein with 35S-methionine (as described above) and then chasing for 1 hour with
DMEM containing 5% FBS and excess unlabeled methionine. The cells were then lysed
in 1x MNT buffer (20 mM MES, 150 mM NaCl, 30 mM Tris, pH 7.5) contatining 1%
TX-100 at the indicated pH (7.4, 6.1, 5.2). After removing the nuclei and cell debris by
centrifugation, the post-nuclear supernatants were incubated with or without TPCKtrypsin for 30 min at 37°C. Digestion was halted by adding 100 trypsin inhibitor units of
aprotonin. G proteins were then immunoprecipitated by incubating with a polyclonal α-
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VSV antibody followed by Pansorbin. A 10% SDS-PAGE gel was used to resolve the
immunoprecipitated G proteins and fluorography was used for visualization.
Characterization of rVSV Encoding Mutant G Proteins
Recovery of Virus Containing Mutated G Proteins. Infectious viruses encoding G
proteins with mutations in the membrane-proximal region were recovered from plasmids
as described previously (Takada, Robison et al. 1997), with a few modifications (Fig 21). Approximately 3x 106 baby hamster kidney cells (BHK-21) were infected with a
recombinant vaccinia virus encoding the T7 RNA polymerase (vTF7-3) (Earl, PL) at an
MOI of 5 for 1 hour at 31°C. The inoculum was removed and the cells were transfected
with a DNA-liposome suspension composed of 5µg of the appropriate pVSV-G mutant
plasmid and 5µg, 3µg, 5µg, and 1µg respectively, of plasmids containing G, N, P, L
genes from VSVIND with 76µl of TransfectAce (Rose, Buonocore et al. 1991; Whitt,
Buonocore et al. 1991). After 4 hrs, the transfection mix was removed and replaced with
DMEM containing 10% FBS. The cells were incubated at 37°C for approximately 48
hrs. 48 hrs post transfection, the supernatants were harvested and filtered through a 0.2µ
filter (Millipore, Millex-GS) to remove any residual vaccinia virus. The filtrate was then
applied to BHK-21 cells in a 35mm dish that had been transfected with 2µg of pCAGGSGIND plasmid 24 hrs earlier. 24-48 hrs later, recovery of the virus was assessed by
examining the cells for cytopathic effects that are typically seen in a VSV infection. All
recombinant viruses were recovered using G-complementation (P1). 200µl of the
recovery supernatant was used to infect BHK-21 cells without G-complementation to
produce rVSV expressing the mutated G protein on the surface (P2). The viruses were
plaque purified (P3), then passaged on BHK-21 cells to make virus stocks (P4).
Plaque Assay. BHK-21 cells (approximately 5 x 105 cells) were plated into each well of
a 6 well plate and infected with 10-fold serial dilutions of the virus at 31°C while rocking
for 1 hour. The inoculum was removed and the cells were overlayed with DMEM+0.9%
agar + 5% FBS and incubated at 37°C for 24-48 hours. Plaques were counted and
averaged between at least two dilutions. Virus titers were expressed as plaque forming
units (PFU)/ml. To determine plaque sizes, the overlay medium that was added consisted
of DMEM + 5% FBS + 1.8% methylcellulose. Approximately 24-48 hours post infection
the overlay was removed and the cells were washed twice with PBS-glycine. The cells
were fixed using 3% paraformaldehyde and stained using α-G I1 monoclonal antibody
followed by a secondary antibody conjugated to either FITC or rhodamine. After
staining the cells, the plaques were imaged using a Zeiss Axiophot epifluorescent
microscope and Axiophot software. The plaques were measured for their diameter
horizontally and vertically. The diameters for 10 plaques were averaged and the area
calculated.
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Figure 2-1. Schematic representing recovery scheme for rVSV encoding mutated G
proteins. BHK-21 cells are infected with vvT7 virus that encodes for T7 RNA
polymerase at an MOI = 5 for one hour. The inoculum is removed and the cells are
transfected with plasmids encoding for N, P, L and G at a 3:5:1:5 ratio for 4 hrs. The
media is replaced with fresh DMEM containing 10% FBS and the cells are incubated at
37°C. Approximately 48 hrs post transfection the supernatants are filtered through a 0.22
µ filter onto BHK-21 cells transiently transfected with pCAGGS-GIND. 24-48 hrs later
the cells were observed for cytopathic effects typically seen in VSV infection.
Supernatants were passaged 3-4 times in the process of obtaining a working stock.
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One-Step Growth Curve. BHK-21 cells were grown to confluency in 35mm plates and
infected with either wt or mutant viruses at an MOI = 10 for 1 hr at 31°C. The inoculum
was removed and the cells were washed three times with serum free DMEM (SFDMEM) to remove residual inoculum. The last wash was replaced with 2 mls of DMEM
+ 10% FBS and the cultures were incubated at 37°C. Every 2 hours for 16 hours an
aliquot of supernatant was removed and the amount of infectious virus was determined
by plaque assay as previously described.
Detection of GS. To measure the amount of cleaved G protein (GS) present in virions,
confluent monolayers of BHK-21 cells were infected at an MOI = 1. At approximately
16 hours post infection, the supernatant was collected, clarified of cells and cell debris by
centrifugation at 2500 RPM for 5 minutes and the virus particles were then pelleted by
ultra-centrifugation at 100,000 x g for 35 min through a 20% sucrose cushion. The viral
pellets were resuspended in 100µl of reducing sample buffer and 5µl was loaded on a
10% SDS-PAGE gel to resolve the proteins. One gel was stained with commassie blue,
while a duplicate gel was used for western blot analysis. Samples were transferred to
PVDF membrane (Millipore), the membrane was blocked in 5% bovine serum albumin
(BSA) for 30 min at room temperature, and then polyclonal rabbit α-G-tail antibody was
used as the primary antibody at a 1:500 dilution in blocking buffer and incubated at room
temperature for 30 minutes. The blot was then incubated with anti-rabbit antibody
conjugated to Horseradish Peroxidase (HRP) at a 1:20,000 dilution for 30 minutes.
Proteins were then detected by treating the blot in HRP detection substrate (Millipore).
Selection of Plaque Isolates. To identify virus variants within the recovery supernatants
(Fig 2-1), a standard plaque assay was performed as described. Ten plaques of various
sizes were selected and removed from the plate using a Pasteur pipette and resuspended
in 500µl of DMEM containing 5% FBS for 4-5 hours. The supernatant containing the
plaque isolate was then was used to infect a 35mm plate of BHK-21 cells at an MOI = 10.
Approximately 6 hrs post infection the media was removed, RNA was extracted, reverse
transcribed, PCR amplified using MW36 (forward) and 3464 (reverse) primers
(Table 2-1), and the resultant cDNA was used for sequencing (as described previously).
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Chapter 3: Mutational Analysis of the Membrane-Proximal Region of VSV G
Introduction
Vesicular stomatitis virus is an enveloped, negative-sense, nonsegmented, RNA
virus belonging to the Rhabdovirus family and the Mononegavirales order. Like other
enveloped viruses, entry into the host cells is dependent upon a fusion event between the
virus and cell membranes that is mediated by the outer surface glycoprotein, G. G
protein attaches to an unknown receptor on the host cell surface (Coil and Miller 2004)
and is internalized via receptor mediated endocytosis (Matlin, Reggio et al. 1982).
Fusion of the viral envelope and the host cell endocytic membrane is triggered by the
decrease in pH within the endocytic environment. When the pH reaches between 6.2 and
6.3, initial conformational changes in G are triggered leading to exposure of the fusion
loops and insertion in to the target membrane. Further conformational changes then
occur forming a hairpin structure that pulls the two opposing membranes together.
Formation of the hairpin (six-helix bundle) structure allows for the initial mixing of the
outer leaflets of the opposing membranes, which is referred to as hemifusion
(Chernomordik, Melikyan et al. 1987; Lentz, Malinin et al. 2000). Once the lipids from
the outer leaflets have mixed forming the hemifusion intermediate, a stalk is formed in
which the outer leaflets have collapsed while the inner leaflets remain intact (Jahn and
Sudhof 1999; Kuzmin, Zimmerberg et al. 2001). Finally a fusion pore forms at the
fusion site in which the viral nucleocapsid can possibly pass through or the pore may
expand further to allow for release into the host cell cytoplasm. Fusion pores have been
observed through patch-clamp experiments with cells expressing influenza HA
(Melikyan, Niles et al. 1993; Melikyan, Niles et al. 1993; Zimmerberg, Blumenthal et al.
1994; Blumenthal, Sarkar et al. 1996). Regardless of the type of fusion protein or the
lack of sequence or structural homology, they all undergo a series of conformational
changes that expose a hydrophobic membrane interacting region (fusion peptide or fusion
loop) and pull the two membranes together.
The structural rearrangements that VSV G undergoes when exposed to low pH are
different than what is seen with the well characterized class I fusion proteins, such as
influenza HA, and are also different from the changes that are observed in members of
class II fusion proteins. A key feature that is different in G mediated fusion from the
fusion proteins grouped in either class I or class II is the reversible nature of the low pH
triggered conformational changes observed for VSV G. There is a pH dependent
equilibrium between the pre- and postfusion conformations that is shifted toward the
postfusion form when exposed to low pH (Roche and Gaudin 2002). Prior to
determination of the 3-dimensional crystal structures of the two forms of VSV G (Roche,
Bressanelli et al. 2006; Roche, Rey et al. 2007), extensive mutational analysis of G was
employed to identify regions of the protein that participate in membrane fusion. A
putative fusion peptide was identified by mutational analysis and photolabeling
experiments to residues 118-136 in the VSV G ectodomain. This region was believed to
insert into target membranes when exposed to a low pH environment (Whitt, Chong, et
al. 1989; Li, Drone et al. 1993; Zhang and Ghosh 1994; Durrer, Gaudin et al. 1995;
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Fredericksen and Whitt 1995). Deletions and insertions of residues between 395 and 418
also affected the ability of G to induce membrane fusion (Shokralla, Chernish et al.
1999). Furthermore, when double mutants were constructed containing changes to
residues in both of these regions, fusion was affected in an additive manner, indicating a
possible interaction between these residues (Shokralla, Chernish et al. 1999). These data
were confirmed with the solution of the crystal structures of G in the neutral pH (or
prefusion) and low pH (or postfusion) conformations (Roche, Bressanelli et al. 2006;
Roche, Rey et al. 2007). Interestingly, the structures revealed a unique feature in that
there were two loops extending toward the viral membrane in the prefusion conformation
and both of these likely insert into the target membrane upon low pH induced
conformational changes. These two loops were proposed to make up a bipartite fusion
peptide, similar to what has been suggested for the Viral hemorrhagic septicemiavirus
(Gaudin, de Kinkelin et al. 1999).
To understand the role of the membrane-proximal stem region (MPR) of G we
employed a mutational analysis coupled with cell-cell fusion and virus infectivity assays.
Since no structural data exists for the MPR, we chose to mutate charged residues,
histidines that can form salt bridges with the charged residues (Carneiro, Stauffer et al.
2003; Roche, Rey et al. 2007), or highly conserved residues. We initially characterized
the mutated G proteins based on surface expression and cell-cell fusion capacity. Those
mutant G proteins with cell-cell fusion phenotypes different from that of wild type were
examined for their ability to undergo pH dependent conformational changes. We also
recovered recombinant virus encoding mutated G proteins to examine the effects of the
mutations on the infectivity of the virus.
Results
Mutagenesis of the Membrane-Proximal Region of G. To investigate the role of the
membrane-proximal region of VSV G we employed a mutational analysis, focusing on
highly conserved residues as well as residues that are conserved for their chemical
properties. Available sequences from VSV-Indiana San Juan strain, (Rose and Gallione
1981), VSV New Jersey (Gallione and Rose 1983), Chandipura virus (Masters, Bhella et
al. 1989), Cocal virus (Bhella, Nichol et al. 1998), Isfahan virus (Marriott 2005), Piry
virus (Brun, Bao et al. 1995), and spring viremia of carp virus (SVCV) (LecocqXhonneux, Thiry et al. 1994) were aligned, revealing several completely conserved
amino acids as shown in yellow (Fig 3-1A) . Several residues in this region are
completely conserved, while others are functionally conserved based on their chemical
properties as depicted with turquoise color. Many residues in this region were also
conserved for their chemical properties and are represented with a green background.
Some interesting features within this region are the conserved HPH motif (H423, P424,
and H425) as well as the conserved acidic residues D435, D436, and E437. Residues 440
and 441 are conserved among the closely related vesiculoviruses in the alignment, with
phenylalanines at both positions. In the New Jersey serotype G these two positions a
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Figure 3-1. Sequence alignment of closely related vesiculoviruses and mutations
made. (A) Sequences from various strains of vesiculoviruses were aligned using Vector
NTI Software (Alignx), to identify residues in this region of the protein that are
completely or highly conserved. The strains of vesiculovirus shown are from VSV
Indiana (Rose and Gallione 1981), VSV New Jersey (Gallione and Rose 1983),
Chandipuria virus (Masters, Bhella et al. 1989), Cocal virus (Masters, Bhella et al. 1989;
Bach, Bringmann et al. 1990; Bhella, Nichol et al. 1998), Isafan virus (Marriott 2005),
Piry virus (Brun, Bao et al. 1995), and spring viremia of carp virus (SVCV) (LecocqXhonneux, Thiry et al. 1994). Residues with a yellow background represent
conservation among all of the vesiculoviruses aligned. Residues with a turquoise
background are almost completely conserved with only one exception and residues with a
green background are those with similar biophysical properties. (B) Mutations that were
made to the G protein from the Indiana serotype (San Juan strain) are shown.
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tyrosines, which strongly resemble phenylananine in that they both are bulky, strongly
hydrophobic, and contain a conjugated ring system. T445 and G446 were completely
conserved as were N449 and P450, suggesting a possible role for these residues in the
function of the protein. Two tryptophan residues are completely conserved in this
sequence alignment. Studies with HIV-1 env revealed a key role for conserved
tryptophans in both env mediated membrane fusion and virus budding (Salzwedel, West
et al. 1999). Theses two conserved tryptophans in VSV G residues were previously
mutated to determine their importance for entry and budding, but surprisingly, these
experiments revealed no critical role in either process (Jeetendra, Ghosh et al. 2003).
To examine the contribution of the conserved residues in the membrane proximal
region to the fusion activity of G protein, I made substitutions and deletions (Fig 3-1B).
The HPH motif was deleted (ΔH423-H425) as well as replaced with alanines
(H423A/P424A/H425A). H425, individually, was also deleted or replaced with an
alanine. D435-E437 was mutated to alanines as were F440/F441, T445/G446, and
N449/P450. These mutants were initially characterized for surface expression, fusion
capacity, and the ability to undergo low pH induced conformational changes.
Surface Expression of VSV G Mutants. To determine if the mutations affected the
transport from the ER to the Golgi or cell surface expression of the mutant G proteins,
Endo H resistant assays and flow cytometry were performed on cells expressing each of
the mutants. BHK-21 cells were transfected with plasmids expressing either wild type or
mutant G proteins and the cells were processed for indirect immunofluorescence
microscopy using a G specific mAb (I1) (Lefrancois and Lyles 1982) as an initial screen
for surface expression. The initial screen indicated that all the mutated G proteins were
expressed on the cell surface, but the G proteins with mutations made to the HPH motif
appeared to be expressed at lower levels than that of wild type G protein (data not
shown). Flow cytometry was then used to quantify the levels of surface expression and
the surface expression was described as relative florescence intensity based on the
percent of cells expressing G and the mean fluorescence intensity of those cells (Fig 3-2).
Deletion of H423- H425 or substitution of all three residues to alanines resulted in a
dramatic decrease in surface expression of the G protein to ~20% that of wild type levels.
However, the single mutation of H425 to an alanine resulted in a protein that was
expressed at levels ~70% that of wild type. Substitution of D435-E437 with alanines
resulted in near wild type levels of expression, while F440A/F441A showed a reduction
in surface expression to ~35% that of wild type levels. When T445-G446 and N449P450 were mutated to alanines the levels of surface expression was also similar to wild
type (Fig 3-2). Flow cytometric data from those mutants with a reduced level of surface
expression (ΔHPH, H423A/P424A/A425A, ΔH425, and F440A/F441A) revealed that
approximately 50% of the cells were expressing G as determined by the percent parent
cells expressing. However, the mean fluorescence intensity was greatly reduced as
compared to wild type, explaining the relative fluorescence intensity amounts described
above (Table 3-1). These results indicate that the cells transfected with plasmids
encoding the G proteins with mutations to the HPH or FF motifs were expressing the
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Figure 3-2. Cell surface expression of glycoprotein mutants. BHK-21 cells were
transiently transfected with 2µg of plasmid encoding the indicated G protein.
Approximately 24 hr later, cells were prepared for flow cytometry using a monoclonal
antibody directed to G (I1) and a secondary antibody conjugated to FITC. Expression
levels represent relative surface expression. Relative surface expression = (% positive
cells in mutant population x mean fluorescence intensity) / (% WT positive cells x WT
mean fluorescence intensity). Values are expressed as a percentage of WT surface
expression, which was set at 100%. Averages of three separate experiments were
calculated with standard deviations shown.
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Table 3-1. Percent parent expressing cells and mean fluorescence intensity values.
Protein
MCS
Wt G
H423A/P424A/H425A
ΔH423/P424/H425
ΔH425
H425A
D435A/D436A/E437A
F440A/F441A
T445A/G446A
N449A/P450A

Percent Parent
0.5%
87.7%
38.2%
45.4%
51.4%
73.7%
77.7%
57.5%
88.4%
77.1%
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Mean Fluorescence
Intensity
1036
10950
2722
3296
4957
9646
9657
5617
10320
10849

protein but at significantly lower levels than what is observed for wild type. Since these
proteins appear to be expressed at lower levels, the next step in characterization is to
determine whether these mutants are able to be transported from the ER to the Golgi and
if so, the rate at which this occurs.
To examine the transport kinetics of the mutant G proteins that showed greatly
reduced cell surface expression as compared with wild type G, Endoglycosylase H (Endo
H) analysis was used (Fig 3-3). While in the ER, G (or other membrane bound or
secreted proteins) acquire high mannose oligosaccharides. At this stage in the secretory
pathway, the proteins are sensitive to Endo H digestion. The protein then moves from the
ER to the medial Golgi where the high mannose oligosaccharides are cleaved by Golgi
mannosidase II, resulting in complex oligosaccharides that are resistant Endo H
digestion. Acquisition of Endo H resistance, therefore can be used to compare rates at
which the mutated proteins migrate from the ER to the Golgi, or if they do at all. The
ΔH423/P424/H425 and H423A/P424A/H425A mutants acquired EndoH resistant sugars
more slowly than wild type and after 60 minutes were still not entirely resistant to
digestion. H423A/P424A/H425A does not have a band in the treated or untreated lane at
the 15 minute time point likely due to an inefficient transfection (the treated and
untreated samples for each time point came from one plate of transfected cells). Since
complete Endo H resistance was not observed even after 60 minutes, the lack of protein
in the 15 minute samples does not impact the interpretation of the data. The transport
kinetics of ΔH425 and F440A/F441A were more similar to that of wild type in that by 30
minutes these proteins were completely resistant to Endo H digestion, but perhaps
slightly reduced in rate based on the amount of resistance at 15 minutes. From this
experiment it appears that, surprisingly, ΔH425 and F440A/F441A are moving from the
ER to the medial Golgi at a similar rate as compared to wild type. This finding is
particularly surprising for the ΔH425 mutant that is reduced in surface expression by
~80% from that of wild type. The next step in the characterization of the mutated G
proteins is to examine the fusion capacity through the use of a syncytium formation
assay.
Cell-Cell Fusion Activity of Mutants. The functionality of these mutated G proteins was
examined based on the premise that fusion proteins can be transiently expressed in cells
and mediate cell-cell fusion. Syncytium formation can then be observed as a means by
which to quantify the fusion capacity of a protein. Likewise, cells can be infected with
virus and treated with fusion media to observe syncytium formation. BHK-21 cells
expressing either wild type G protein or the mutants individually were treated with fusion
media buffered to pH 6.0 or 7.0 as an initial screen for fusion capacity. A separate plate
of cells transfected in parallel was used for flow cytometry to quantify the level of cell
surface expression for the experiment. Cell-cell fusion was not observed for several of
the mutants. The ΔH423/P424/H425, ΔH425, H423A/P424A/H425A, F440A/F441A,
and D435A/D436A/E427A mutants all showed no cell-cell fusion based on a lack of
syncytium formation in the plates treated at pH 6.0 (data not shown). All of these
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Figure 3-3. Transport kinetics of mutants with reduced surface expression. BHK-21
cells were transfected as described in figure 3-2. Approximately 12 hr later, the cells
were metabolically labeled with 35S-methionine, chased with medium containing excess
non-radioactive labeled methionine for the times indicated, and immunoprecipitated
using a polyclonal α-VSV antibody (TN-1). The precipitated proteins were then digested
with Endo H and analyzed on a 10% SDS-PAGE gel.
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mutants, with the exception of D435A/D436A/E437A, were expressed at lower levels
than wild type on the cell surface as assessed by flow cytometry (data not shown).
Based on the reduced cell surface expression, two possible conclusions could be
drawn. It has previously been suggested for rabies virus that approximately 13 to 19
trimers are needed at the fusion site to cause membrane coalescence (Roche and Gaudin
2002), and therefore, a decreased amount of protein on the cell surface could prevent
fusion from occurring. Alternatively, the mutations, while important to proper folding
and surface expression, may also affect a critical step in the fusion process. To examine
these possibilities, BHK-21 cells were transfected using varying amounts of plasmid
expressing wild type G and mutant G proteins such that the surface expression levels of
wild type was less than or equal to that of the mutants. The cells were treated with fusion
media buffered to pH 5.2, 5.5, 6.0, or 7.0 to also examine the possibility that the
mutations may have resulted in a decrease in the threshold pH required for fusion.
Interestingly, the ΔH423/P424/H425 mutant when expressed on the cell surface at
a level greater than that of wild type, showed no cell-cell fusion activity at any of the pHs
examined (Fig 3-4). These data indicated that ΔH423/P424/H425 is a fusion defective
mutant. Analysis of the ΔH425, D435A/D436A/E437A, and F440A/F441A mutants,
(when expressed on the cell surface at levels greater than that of wild-type) revealed
minimal fusion at pH 6.0 as compared with wild type G protein (Fig 3-5A). These results
indicate that the ΔH425, D435A/D436A/D437A, and F440A/F441A mutants have a
reduced pH threshold for fusion. H423A/P424A/H425A was expressed at a lower level
than wild-type in all experiments so conclusions on the fusion capacity could not be
drawn. To quantify cell-cell fusion in these experiments, cells that had not fused in three
separate fields of view were counted, averaged, and subtracted by the number of cells
unfused in the plates that had been treated with neutral pH buffer. These data further
confirmed a reduced threshold for cell-cell fusion activity that was initially observed for
the ΔH425, D435A/D436A/E437A, and F440A/F441A mutants. Likewise, the
ΔH423/P424/H425 mutant was completely fusion defective at each pH examined.
Analysis of pH Dependent Conformational Changes. Since several mutants showed
defects or a reduction in fusion activity, I wanted to determine if these mutants could
undergo pH dependent conformational changes. It has been shown that VSV G in the
prefusion form is sensitive to trypsin digestion and as the pH decreases the protein
becomes more resistant to digestion (Fredericksen and Whitt 1996). Acquisition of
trypsin resistance is believed to be a result of the large scale conformational changes that
occur in G when exposed to a pH below 6.3. Therefore, this assay is used as a tool to
identify if the mutations made to the G protein interfere with the ability to undergo the
pH triggered conformational changes. To determine if the mutations made in the
membrane-proximal region of G affected pH dependent conformational changes, cells
expressing either wild type or a mutant G protein were lysed in a detergent solution
buffered to pH 5.2, 6.1, or 7.4 and treated with TPCK-trypsin for 30 minutes at 37°C.
The reaction was stopped by the addition of aprotonin and lysates were
immunoprecipitated using a polyclonal α-VSV antibody and then analyzed on a 10%
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Figure 3-4. Cell-cell fusion in transiently transfected cells. BHK-21 cells were
transiently transfected with varying amounts of plasmid encoding the mutant proteins to
set the expression levels greater than or equal to wild type. Approximately 20 hours post
transfection, the cells were treated in media buffered to pH 7.0, 6.0, 5.5, or 5.2 and
images were collected using a Zeiss Axiophot camera and Axiophot software. Arrows
indicate syncytium formation.
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Figure 3-5. Quantitation of cell-cell fusion. (A) Quantitation of the experiment
described in figure 3-4 was done by counting the number of unfused cells in three
separate fields of view per condition and averaging the results. The number of unfused
cells was then subtracted from the total average number of cells in wells treated at neutral
pH to obtain the number of cells fused. Percentage of fused cells was then determined by
dividing the number of fused cells in the low pH wells by the number of cells in the wells
treated with fusion media buffered to pH 7.0. (B) Cells from a separate well were
transfected at the same time as those used for the fusion assay and used for flow
cytometry to measure surface expression.
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SDS PAGE gel. All of the mutants examined became sensitive to trypsin digestion at
similar pH values as wild type indicating that the mutations do not interfere with the
ability of the glycoprotein to undergo acid induced conformational changes required for
fusion (Fig 3-6). The next step in characterizing the effects of the mutations on the G
proteins is examination of virus infectivity.
Recovery of Recombinant Mutant VSV. Reverse genetics was employed to recover
recombinant VSV encoding the mutant G proteins to assess the impact that these
mutations have on the ability of the virus to grow and spread. All viruses were recovered
using G complementation to compensate for any potential fusion defects and to help in
the successful recovery of recombinant virus. H423A/P424A/H425A was the only virus
that was unable to be recovered after multiple attempts, despite complementation with
wild type G. This mutant was expressed at significantly lower levels than wild type and
therefore could not be examined in terms of fusion. In contrast, all the other mutants
were recovered on the first or second attempt. ΔH423/P424/H425 was completely fusion
defective in the initial fusion assays using transient transfections and was able to be
recovered using G complementation, and as expected, produced viral particles that were
not infectious (data not shown). Recovery of recombinant VSV encoding
ΔH423/P424/H425 was detected by staining the cells with α-N monoclonal antibody
(10G4) as well as observation of VSV induced cytopathic effects. After recovery of wild
type G complemented recombinant virus encoding ΔH423/P424/H425, the recovery
supernantant was used to infect cells to produce virus expressing the mutated G protein
on the virion surface. Subsequent infection of fresh cells with the ΔH423/P424/H425
resulted in no cytopathic effects, indicating the virus was not infectious. The recovered
recombinant viruses containing the mutated G proteins were then characterized based on
their growth kinetics, surface expression, and fusion capacity.
One-Step Growth Curve. To determine the growth kinetics of the viruses encoding the
mutated G proteins, a one-step growth curve was performed. The cells were infected with
mutant and wild type virus (that had been titered in duplicate) at an MOI of 0.1 pfu and
rinsed three times after the infection, before replacing the inoculum with fresh media to
help ensure the initial infection was the same for all viruses. Interestingly, titers for
rVSV-H425A, rVSV-D435A/D436A/E437A and rVSV-T444A/G445A initially were
lower than that of Wt, but by 4 hrs post infection reached wild type levels (Fig 3-7A).
Surprisingly, D435A/D436A/E43A, which appeared to have a decrease in the pH
threshold for fusion (Fig 3-3, Fig 3-4), was able to grow to near wild type titers
suggesting efficient fusion activity (entry). Likewise, rVSV-H425A, T444A/G445A, and
N449A/P450A all grew to wild type titers, as expected based on the cell-cell fusion and
surface expression phenotypes observed (Fig 3-2 and 3-5).
The recombinant viruses all reached wild type titers by 4 hours post infection and
maintained near wild type levels through 16 hours (Fig 3-7A). At 16 hours post infection
the supernatants were harvested, virus was pelleted by centrifugation through a 20%
sucrose cushion and an aliquot was analyzed for protein content by SDS-PAGE. As was
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Figure 3-6. pH dependent protease sensitivity. BHK-21 cells were transfected with
the appropriate plasmid DNA, metabolically labeled with 35S-methionine, lysed with
detergent (TX-100) buffered to the indicated pH (7.4, 6.1, or 5.2), treated or not treated
with trypsin-TPCK, and then immunoprecipitated using a polyclonal α-VSV antibody
and analyzed by SDS-PAGE
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Figure 3-7. One-step growth curve measuring virus infectivity. (A) BHK-21 cells
were infected at an MOI = 10 for 1 hour. The cells were washed two times to remove
any unbound virus and the supernatants were collected over 16 hours and used in a
standard plaque assay to determine the titer at various times post infection. (B) The titers
at 16 hours from three individual experiments were averaged and expressed PFU/ml. (C)
Virus purified from the supernatant of the infections in (B) were analyzed by SDS-PAGE
and the gel was stained with Coomassie to visualize viral proteins released from cells
after 16 hours.
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expected based on the one-step growth curve, similar amounts of virus were released
compared to wild type and the amount of G protein incorporated appeared to be similar to
wild type virus (Fig 3-7B and 3-7C).
To further assess the replication capacity of viruses encoding the mutated G
proteins, plaque sizes from a standard plaque assay were examined by staining with the
monoclonal antibody, I1, which is directed to G. All of the plaque sizes were comparable
to those of wild type VSV, with only the T44A/G445A mutant being slightly reduced
(Fig 3-8). These data confirm what was seen in the one-step growth curve, indicating
that the mutations did not affect the growth or spread of the virus at late time points post
infection. Since the recombinant VSV encoding the G protein with the T444A/G445A
mutation reached wild type titers the reduced plaque does not likely indicate a growth
defect. Interestingly, the plaque assay further confirmed the results seen in the standard
growth curve indicating the D435A/D436A/E437A mutant grew and spread like wild
type. These results were surprising based on the decrease in pH required to trigger cellcell fusion in transiently transfected cells.
Surface Expression and Fusion in Virally Infected Cells. A previous report showed
that some viruses encoding G proteins with minimal fusion capacity in transient
transfection assays can still be infectious in the context of virus infection (Cross, Wharton
et al. 2001; Jeetendra, Ghosh et al. 2003). These results were explained by suggesting
that a small fusion pore is able to form, allowing for transfer of the nucleocapsid into the
cell but not large enough for polykaryon formation. To examine this possibility, cells
were infected with the rVSV mutants, and cell surface expression was measured by flow
cytometry at 6 hours post infection using a monoclonal G antibody (Fig 3-9). Surface
expression of the mutated G proteins was similar to that of wild type. Also, a fusion
assay was conducted at the same time point post infection (6 hours) in which the cells
were treated with fusion media buffered to pH 6.1, or 5.8. As expected the H425A
mutant and the N449A/P450A mutant showed wild type or greater fusion levels (Fig 310). Unexpectedly, the D435A/D436A/E437A mutant also fused like wild type in the
viral cell-cell fusion assay.
Presence of Cleaved G on the Recombinant VSV Virion. Since the phenotypes of the
D435A/D436A/E437A mutant in experiments involving transiently transfected cells did
not correlate with those observed in the context of virus infected cells, I wanted to
examine the amount of cleaved G on the virion surface. VSV has been shown to have a
population of G on its virion surface that has been cleaved, leaving the membrane
proximal domain, transmembrane domain, and cytoplasmic tail (GS). Experiments have
indicated that this truncated G protein can potentiate the activity of fusion proteins that
either are defective or do not fuse on their own (Robison and Whitt 2000; Jeetendra,
Robison et al. 2002). Based on these findings, I hypothesized that the difference
observed in the transient plasmid-expressed cell-cell fusion assays and the virus
infectivity/virus infected cell-cell fusion assay may be due to an enhanced cleavage of
D435A/D436A/E437A and the higher level of GS may help to overcome the defects in
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Figure 3-8. Plaques of wt and mutant VSV. (A) Standard plaque assay was performed
followed by staining the cells with a G specific monoclonal antibody, I1. Plaques labeled
rVSV-wt represent the wild type plaques observed in the same experiment as the panels
to the right of the control (B) Relative plaque sizes were determined by photographing
plaques using a Zeiss axiophot camera and Axiovision software, enlarging the
photographs and measuring the diameter horizontally and vertically. The diameters were
averaged and used to calculate the relative area of the plaques. The data represent the
average measurements from three separate plaques expressed as a percentage of wild
type.
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Figure 3-9. Surface expression in virally infected cells. BHK-21 cells were infected at
an MOI=10 at 31°C. After 1 hr the media was replaced with fresh DMEM containing 5%
FBS and the cells were transferred to 37°C. 6 hrs post infection the cells were fixed and
processed for flow cytometry using a G monoclonal antibody, I1 followed by a secondary
antibody conjugated to FITC. Relative surface expression was calculated as described in
Fig 3-2.
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Figure 3-10. Cell-cell fusion in virally infected cells. BHK-21 cells were infected with
the indicated virus as described in figure 3-9. At 6 hours post infection, the cells were
treated with fusion media buffered to pH 7.0, 6.1, or 5.8 for 1 minute at room
temperature. The fusion buffer was replaced with DMEM plus 5% FBS and the cells
were incubated at 37°C for 30 minutes. Cell-cell fusion was quantitated by counting cells
in three separate fields of view and subtracting from the total cell number. Relative
fusion index was then calculated by dividing the number of fused cells from the number
of unfused cells at pH 7.0.
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fusion activity. To examine this possibility, purified virus was immunoblotted using an
antibody that binds to the cytoplasmic tail (C-tail) of G. As shown in figure 3-11 there
was more GS detected in the cells infected with the recombinant VSV encoding the G
protein containing the D435A/D436A/E437A mutation. The rest of the viruses
containing mutated G proteins appeared to have similar amounts of GS as was seen with
wild type (data not shown).
Discussion
Determination of crystal structures from VSV G (Roche, Bressanelli et al. 2006;
Roche, Rey et al. 2007) and herpes simplex virus gB (Heldwein, Lou et al. 2006) led to
classification of a new group of fusion proteins, the class III proteins, as previously
mentioned. More recently, the structures of the baculovirus gp64 (Kadlec, Loureiro et al.
2008), and the Epstein-Barr virus gB (Backovic, Longnecker et al. 2009) fusion proteins
were solved, revealing structural homology to the herpes gB and VSV G fusion proteins,
further supporting the need for a third classification. VSV G is the only class III fusion
protein in which both pre- and postfusion structures have been solved. Availability of the
structures provides a wealth of information in regard to the structural transitions that take
place when the protein is exposed to low pH in the endosome during viral entry.
However, G protein was cleaved upstream of the membrane-proximal region for
successful crystallization, therefore, no structural information exists for this region.
Likewise, crystal structures of other fusion proteins have had the same limitation,
resulting in the absence of structural data to help understand the contribution of these
regions to the fusion event.
We chose to employ a mutational analysis approach in an effort to determine if
individual residues within the membrane proximal region of VSV G are needed for
membrane fusion. Previous mutational analyses of G in which large deletions or
insertions were made suggested a role for this region in the membrane fusion process
(Jeetendra, Ghosh et al. 2003). The large insertions and deletions indicated the size of
this region may be important to G mediated membrane fusion, however did not determine
if individual residues may be critical. Sequence alignment of a number of closely related
Vesiculoviruses revealed a high level of conservation of the residues in this region
(Robison and Whitt 2000) (Fig 3-1). The crystal structure in the post fusion conformation
extends to the H407. H407 correlates with the histidine at position 423 that is described
in this chapter. The numbering differs between the crystal structure and the work
presented here is because the crystal structure numbering represents the G protein with
the signal sequence cleaved (16 residues) and the numbering of residues in this chapter
includes the signal sequence. H407 (H423) is shown to participate in a salt bridge with
an aspartate in the post fusion conformation (D137 in crystal structure). Based on the
crystal structures, the authors conclude that the pH dependent conformational changes are
driven by the protonation of specific histidine residues. The direct role of histidines in
pH dependent conformational changes required for fusion was earlier hypothesized based
on chemical modification of various histidine residues in G protein, resulting in
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Figure 3-11. Presence of cleaved G protein on the virion. BHK-21 cells were infected
with either wild type VSV or rVSV-D435A/D436A/E437A at an MOI=10 for 16 hours
then supernatants were analyzed by SDS-PAGE and either treated with Coomassie to
visualize amount of virus or immunoblotted using a polyclonal G antibody specific to the
C-tail.
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abolished fusion activity of VSV G (Carneiro, Stauffer et al. 2003). Furthermore, when
the chemical modification was reversed, cell-cell fusion capacity was restored. As
mentioned previously, VSV G is unique in that the conformational changes that occur
when exposed to acidic pH are completely reversible (Roche and Gaudin 2002). Another
interesting feature of this fusion protein is the constant association and dissociation of G
trimers (Lyles, Varela et al. 1990; Zagouras, Ruusala et al. 1991; Zagouras and Rose
1993). Due to these characteristics, G may require specific interactions to stabilize the
states needed for the fusion event. The structural data for G suggests that in the prefusion
conformation, the fusion domain and the membrane proximal region interact to stabilize
the structure. Exposure to low pH interrupts these interactions, releasing the fusion
peptide and propelling it toward the target membrane. The final conformational changes
involve the formation of salt bridges between acidic residues and protonated histidines to
help lock G in the postfusion structure that pulls the two membranes together to allow for
membrane fusion (Roche, Bressanelli et al. 2006; Roche, Rey et al. 2007).
The first step in characterization of these mutant G proteins was to assess their
expression levels. H425A, D435A/D436A/E437A, T445A/G446A, and N449A/P450A
were all expressed on the cell surface at levels similar to that of wild type. Both the TG
motif and the NP motif are completely conserved among the Vesiculoviruses aligned (Fig
3-1), however, it appears these residues are not conserved for their role in proper folding
of the protein. ΔHPH, H423A/P424A/H425A, ΔH425, F440A/F441A were all expressed
at levels greatly reduced from that of wild type. These findings suggest that the HPH and
FF motifs have critical roles in the proper folding of G for localization to the cell
membrane. To examine further the folding of these proteins and the movement through
the secretory pathway, an Endo H analysis was employed. Wild type G is typically
transported to the trans-Golgi apparatus with a half time of 18-20 minutes (Doms, Keller
et al. 1987; Balch 1989; Machamer, Doms et al. 1990). The results from the endo H
analysis revealed the ΔH423/P424/H425 mutant was slower in transport kinetics as
compared to wild type G, as was expected based on the reduced expression levels.
Interestingly, the ΔH425 and F440A/F441A mutants appeared to acquire resistance to
Endo H digestion at around the same time point as wild type G (~ 30 minutes) and by 60
minutes were completely resistant to Endo H digestion, indicating the protein should be
expressed on the cell surface at levels similar to wild type G. Expression levels for the
ΔH425 mutant were observed to be reduced by ~80% as compared to wild type G
protein, however, the lower level of surface expression did not appear to be due to
inefficient transport to the cell surface. Surface expression levels were determined by
flow cytometry, using a G specific monoclonal antibody (I1) for detection while in the
Endo H assay, G was immunoprecipitated using a polyclonal anti-VSV antibody. One
possible explanation for the disconnect in surface expression levels and the kinetics of
transport observed for these mutant G proteins is that the I1 antibody epitope becomes
partially hidden with a slight misfold in the protein. Less efficient binding of the I1
antibody would cause the data to indicate the expression levels were reduced. However,
the Endo H resistance would not be affected because this experiment uses a polyclonal
anti-VSV antibody. To address this possibility, surface expression should also be
examined in a biotinylation assay. The kinetics of transport are reduced as compared to
wild type for the HPH deletion mutant and H423A/P424A/H425A mutant, while the
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ΔH425 and F440A/F441 mutants acquire resistance to Endo H digestion by 30 minutes as
is seen with wild type. Both the ΔH423/P424/H425 and H423A/P424A/H425A mutants
are more reduced in surface expression than is seen in the ΔH425 and F440A/F441A
mutants. Perhaps, these mutants are able to stabilize the prefusion form slightly better
than those with the HPH motif deleted or mutated. The pH in the secretory pathway
plays a pivotal role in the efficient posttranslational modifications and processing of
proteins (Carnell and Moore 1994). As the proteins progress along this pathway the pH
decreases. In the endoplasmic reticulum the pH is neutral (~7.2) (Kim, Johannes et al.
1998; Wu, Grabe et al. 2001). The cis-Golgi has a pH of around 6.7 (Kim, Lingwood et
al. 1996) and the pH decreases to around 6.0 in the trans-Golgi (Seksek, Biwersi et al.
1996; Demaurex, Furuya et al. 1998). Perhaps, if the mutations made to the MPR of the
G protein affected pH dependent conformational changes the transport to the cell surface
was also affected because the proteins could be in a different conformation than the wild
type G proteins as they progress through the increasingly acidic environment within the
secretory pathway.
The next step in characterizing the role of the membrane proximal residues in G
was to assess the affects the mutations had on the protein function. Cells transiently
expressing either the wild type or mutated proteins were treated with fusion media. The
fusion media was buffered to pH 7.0, 6.0, 5.5, or 5.2. At pH 7.0 the majority of wild type
G protein should be in prefusion conformation and therefore minimal fusion should be
observed. When the cells expressing the G proteins are treated with fusion media at pH
6.0, extensive cell-cell fusion should be observed in wild type, since the threshold pH for
fusion is around 6.2-6.3. If fusion is observed at this pH one would expect to see fusion
with in the mildly acidic environment of the early endosomes as is observed in wild type
G mediated membrane fusion. Treatment with media at pH 5.5 as well as 5.2 represents
the acidic environment found in the late endosomes. An initial screen to identify mutated
G proteins with fusion defects revealed those with mutations to the HPH, FF, and DDE
motif were fusion defective at pH 6.0. Interestingly, ΔH423/P424/H425 was completely
fusion defective, even at pH 5.2 while mutations to the DDE and FF motifs resulted in a
reduced pH threshold for fusion. VSV G typically is believed to mediate fusion in the
early endosomes where there is a mildly acidic environment that correlates with the
threshold pH required for fusion which is 6.2-6.3. Since the experiment was not done
with smaller increments (0.1 pH units) it remains to be seen at exactly what pH fusion is
occurring and therefore, it is not known at exactly what point in the endocytic pathway
the RNP is released for these mutated G proteins. However, if fusion is not seen until the
pH reaches 5.5 (Fig 3-4, 3-5) one would expect the viral RNP to be released in to the host
cell cytosol from the late endosomes or lysosomes as opposed to the early endosomes.
We hypothesized that the mutated residues in G that caused a reduced capacity for
fusion are likely involved in the structural transitions between the pre- and postfusion
conformations. Therefore, we examined the ability of the G protein to acquire trypsin
resistance when exposed to low pH. The experiment revealed that all of the proteins that
were defective in fusion or required a lower pH for fusion were able to undergo pH
dependent conformational changes (as observed for wild type) making them resistant to
trypsin digestion (Fig 3-6). From these results I concluded that the mutations affected a
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step in the fusion process after the proteins underwent the low pH triggered
conformational changes. This step is possibly the stabilization of the postfusion
conformation. Therefore, the mutated G proteins are able to undergo conformational
changes required for fusion but may not maintain this structure long enough to pull the
two membranes together for membrane merger and pore formation.
Experiments using recombinant virus expressing the mutated G proteins revealed
an interesting disconnect in data. Mutation of the DDE motif resulted in a reduced pH
threshold for fusion in cells transiently expressing the protein. Previous studies in our lab
identified mutants with a reduced pH threshold for fusion that also showed a reduction in
titer as well as plaque size (Fredericksen and Whitt 1998). Based on these previous
findings we expected that those viruses expressing the mutated G proteins with a
decreased threshold pH for fusion would grow to lower titers and produce smaller
plaques as compared to wild type G. Recombinant VSV encoding
D435A/D436A/E437A was recovered and a one-step growth curve was performed.
Surprisingly, the data from this experiment indicated the virus was able to grow and
spread as well as wild type VSV. The growth curve also revealed another interesting
feature. The titers for H425A, D435A/D436A/D437A, T444A/G445A were all over a
log reduced from that of wild type at the two hour time point but by about 7 hours had
reached wild type levels. These data indicate the cells were not initially producing as
much virus but between the 2 and 7 hour time points, produced much more virus. The
viruses with the reduced growth phenotype at two hours possibly are replicating and
making more progeny virus, however the virus is unable to bud through the host cell
plasma membrane to be released. After 2 hours this block is apparently relieved and the
progeny virus that had accumulated in the cell could be released, explaining the steep
increase from the 2 to 7 hour time points. Further experiments would need to be done to
identify the exact step affected by the mutations.
The next step in characterizing the recombinant viruses expressing the mutated G
proteins was to look at the plaque formation. Once again, we were surprised to see the
DDE mutant formed near wild type size plaques. Interestingly the T444A/G445A
mutant’s plaque size was reduced from that of wild type. This mutant was expressed on
the cell surface, had no fusion defect, and grew to wild type titers at 16 hours post
infection. To further examine the fusion activity of the mutated G proteins, surface
expression and fusion capacity was measured in virally infected cells. Data from all of
the viral infections correlated with what was observed in the experiments in which cells
were transiently transfected with the exception of the D435A/D436A/E437A mutant.
This mutant appeared to have a very different phenotype when transfected into cells
versus when cells were infected with virus encoding the mutated G protein. I
hypothesized that G protein was possibly being cleaved, producing more G-stem
(truncated G protein containing C-terminus, transmembrane domain, and a short
ectodomain) on the virion surface.
Previous studies in our lab have shown that the truncated G protein, GS, can
potentiate the membrane fusion of glycoproteins that do not normally mediate fusion on
their own. Furthermore, use of a three color fusion assay showed that GS can induce
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lipid mixing when expressed alone, but cannot proceed to full fusion (Jeetendra, Robison
et al. 2002). Since GS is present on the wild type VSV virion at low levels, we
hypothesized that the mutation may have caused a reduction in cell-cell fusion that the
virus was able to compensate for in the context of infection by producing more GS on the
virion surface.
Based on the hypothesis that acidic residues may form interactions to stabilize G
in the postfusion conformation, we expected to see a reduction or defect in fusion
capacity of the D435A/D436A/E437A mutant. In the context of transient transfections,
we saw a reduction in fusion, however when the recombinant virus was recovered it grew
to wild type levels. GS was detected at seemingly higher levels in the rVSVD435A/D436A/E437A virus in comparison to that of wild type rVSV (Fig 3-11). Efforts
to visualize GS levels in cells transfected with the mutant glycoprotein were unsuccessful
(data not shown) so we can only suggest possible roles the added GS plays since we are
uncertain if there is a population of GS present on the surface of cells transiently
expressing D435A/D436A/E437A. The role of GS during VSV infection has yet to be
understood. To our knowledge this is the first suggestion that GS has a direct role in
efficient entry of the virus.
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Chapter 4: Examination of Variants with Enhanced Growth Phenotypes
Introduction
A hallmark feature of RNA viruses is the very high rate of mutations that arise
during replication. These high mutation rates can be attributed to the error prone RNA
dependent RNA polymerase that is used for replication (Steinhauer, De La Torre et al.
1989; Bilsel and Nichol 1990; Kearney, Donson et al. 1993). RNA viruses make up the
largest group of pathogens affecting humans, animals, and plants. Many riboviruses cause
severe disease in humans, some of these include; Influenza virus, HIV-1, and Ebola virus.
High rates of mutation are believed to be an asset to the viruses as they are better able to
adapt to changing environments and become more fit for infection.
Vesicular stomatits virus has been used as a model for evolutionary virology due
to its broad tropism, simple genetic organization, and ability to be grown to high titers in
cell culture. VSV enters the host cell through receptor mediated endocytosis that is
dependent upon G protein binding to the host cell (Matlin, Reggio et al. 1982). Once the
pH drops in the endosome, G protein undergoes a reversible conformational change
allowing for the bipartite fusion loop to insert into the endosomal membrane (Roche,
Bressanelli et al. 2006; Roche, Rey et al. 2007). Further conformational changes result in
the two opposing membranes being pulled together causing the initial membrane merger
event (hemifusion), stalk formation, and finally formation of a fusion pore in which the
viral nucleocapsid can pass through and be released into the host cell cytoplasm. VSV
replication occurs once the virus has been released into the host cell cytoplasm. Since
VSV does not undergo homologous recombination during replication any base changes
that arise during replication occur due to misincorporation of ribonucleoside
triphosphates because of the error prone RNA dependent polymerase and the lack of
proofreading (Drake 1999; Drake and Holland 1999).
Chapter 3 focused solely on identifying residues within the G protein membraneproximal region of VSV that are important for membrane fusion. Mutations made to
H425 (ΔH425) and F440/F441, within this region, resulted in recombinant viruses that
rapidly acquired second site mutations or changes from the intended mutation. Studies
in this chapter were aimed at characterizing the new mutants that arose from passaging
the viruses. Two variants were observed in the recovery supernantants from the
recombinant virus encoding ΔH425. The variants were; ΔH425/I426S/S438I and
ΔH425/S438I. The recovery supernatants from recombinant virus encoding
F440A/F441A were observed to contain more variants, including; F440V/F441A,
F440T/F440A, F440A/F441A/S438I, and F440A/F440A/CT9 (F440A/F440A/CT9 has a
cytoplasmic tail that is truncated to only 9 residues). Experiments conducted, in chapter
3, using transient transfections resulted in a decreased level of surface expression and a
reduced pH threshold for fusion for the ΔH425 and F440A/F441A mutants (fusion was
observed at pH 5.5 but not 6.0). Therefore the work presented in this chapter
characterizes the variants that arose during passage to identify further residues that may
play a role in the efficient entry and spread of VSV.
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Results
Identification of Rapidly Acquired Mutations. In chapter 3, G proteins with ΔH423 or
F440A/F441A mutations revealed interesting fusion phenotypes in that a reduction in the
pH threshold for fusion was observed. Reverse genetics with G-complementation was
used to recover recombinant VSV encoding G proteins containing these mutations. Since
the cell-cell fusion assays indicated these viruses may have a reduced capacity to enter
cells due the shift in the pH threshold required for membrane fusion activity, the
recombinant viruses were generated using G complementation to help ensure a successful
recovery. Passage on cells not expressing wild type G protein then should produce VSV
with only the desired mutant G protein embedded in the envelope. In chapter 3, when the
plasmids encoding the mutated G proteins were transfected into cells and treated with
fusion media buffered to various pH values, fusion was not observed at pH 6.0 but was
seen at pH 5.5 and pH 5.2. As expected, fusion activity was observed in cells expressing
wild type G at pH 6.0. Since fusion was observed in the transiently transfected cells we
expected to recover virus that was infectious, but that perhaps would grow to lower titers
than wild type G. Prior studies have shown mutations in G that caused a reduction in the
pH required to induce membrane fusion resulted in virus that grew to lower titers than
wild type VSV (Fredericksen and Whitt 1998). Once the viruses were recovered, they
were passaged on BHK-21 cells without G complementation (using 100µl, or 5% of the
recovery supernatant) to produce virus with the mutated G on the virion surface (P1).
Supernatant from this infection was then titered using a standard plaque assay and then a
single plaque was selected and resuspended in 500µl of DMEM + 5% FBS to obtain a
plaque isolate (P2). Supernatant from the plaque isolate (P2) was amplified by another
passage on BHK-21 cells (using 200µl) to generate the P3 stock. Finally after a total of 3
passages on cells without G complementation a working stock of the virus was generated
by infecting at an MOI = 0.1 (P4). The P4 stock of recombinant VSV encoding G with
the ΔH425 mutation grew to a very low titer (~ 6 x 106 PFU/ml). When growing up
additional stocks of the virus I used the P3 working stock to generate a new working
stock (and each successive passage after, for additional stocks), producing later passages
of the virus. Later stocks of the virus (P5 and P6) grew to significantly higher titers (~2 x
107 and 2 x 109, respectively). These findings contrast with what was observed in the
recombinant viruses encoding mutant G proteins that displayed efficient cell-cell fusion
activity. For those mutants (T444A/G445A and N449A/P450A), the titers from the early
stocks were near wild type level (~1 x 109 PFU/ml). The plaque sizes observed from the
initial recovery supernatant (for both ΔH425 and F440A/F441A) were also significantly
smaller than those observed after the virus had been passaged several times (data not
shown).
To ensure the P4 working stocks of the viruses contained G proteins with only the
desired mutations, BHK-21 cells were infected at an MOI = 1 for 6 hours using virus
from the working stock (P4), RNA was extracted from the cells, reverse transcribed, and
PCR amplified using a sense primer upstream of the KpnI site and a nonsense primer in
the 3’UTR of G. The resulting cDNA was used to sequence the G gene and surprisingly,
revealed additional mutations that were not originally present in the plasmids used for
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recovery. The P4 stock of ΔH425 had acquired two additional mutations, I426S and
S438I. Interestingly, virus stock recovered using plasmid encoding F440A/F441A
revealed a F440V/F441A mutation. The original plasmids used in recovery of the
recombinant VSVs encoding the mutated G proteins were re-sequenced confirming that
only the original constructed mutations were present.
Isolation of Plaques to Identify Additional Mutants. Based on the initial observations of
additional mutations arising in the recombinant VSV encoding the mutated G proteins, I
decided to isolate multiple plaques from the original rVSV-ΔH425 and rVSVF440A/F441A recovery supernatants using a standard plaque assay. Approximately 24
hours post infection 10 plaques of various sizes were isolated by using a Pasteur pipette
and being careful to only obtain one plaque at a time. Plaques of various sizes were
chosen in an effort to select for possible variants that grew and spread at different rates.
As described, the plaque isolate was re-suspended in 500µl of DMEM containing 5%
FBS. BHK-21 cells were infected with supernatant from the plaque isolate re-suspension
and RNA extracted from the cells. The viral RNA was reverse transcribed and PCR
amplified using the coding primer, MW36, and the non-coding primer 3464 (Table 2-1)
(Fig 4-1). The entire G gene was sequenced, showing that no additional mutations arose
outside of the membrane-proximal region. Alignment of these sequences with those from
wild type GIND revealed a mixed population of viruses from the original recovery
supernatant (Fig 4-2). The recombinant VSV that was originally cloned to express a G
protein containing only the ΔH425 mutation yielded virus with the intended mutation, but
there was also virus expressing G containing an additional amino acid change at position
438 (serine to isoleucine). None of the plaque isolates observed in this particular
experiment contained a G protein with the double site mutation at I426 and S438
(ΔH425/I426S/S438I). This mutant G was only observed when the initial recovery
supernatant had been passaged 4 times in the production of working viral stocks. Since
this mutant was observed in the working stocks that had been passaged more times than
the plaque isolates the additional I426S mutation likely arose in passaging multiple times
and this mutant will be included in the studies.
When 10 plaque isolates were sequenced from the recovery supernatant of rVSVF440A/F441A, a larger number of variants were observed. The mutations that arose
included; F440V/F441A, F440T/F441A, F440A/F441A/S438I, and F440A/F441A/CT9
(F440A/F441A/CT9 acquired a stop codon in the C-tail that resulted in a tail with only 9
residues). Interestingly none of the plaque isolates contained G proteins with the original
intended mutation, F440A/F441A, that was present in the plasmid used for recovery of
the virus.
Standard Plaque Assay. One means by which to assess the ability of a mutated virus to
grow and spread efficiently is through the use of a standard plaque assay. Figure 4-3
shows representative plaques for each of the mutant viruses that are stained with the G
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Figure 4-1. Selection of plaque isolates. Initial recovery supernatants from viruses
encoding ΔH425 and F440A/F441A were titered using a standard plaque assay. 24 hrs
post infection, plaques of various sizes were picked and resuspended in 0.5ml DMEM
containing 5% FBS. Virus in 0.2ml of the eluted plaque isolate was used to infect ~ 5 x
105 BHK cells and RNA was extracted from cells at 6 hours post infection, reverse
transcribed, and PCR amplified . The resulting cDNA was then sequenced (University of
Tennessee Health Science Center Molecular Resource Center). Alternately, an aliquot of
the eluted plaque isolate was titered on BHK-21 cells and used to infect a 10 cm plate at
an MOI = 0.1 to grow up a working stock. RNA was extracted from the cells used to
grow up the working stock, reverse transcribed, and PCR amplified.
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Translation of DeltaH425 plaque 1
Translation of DeltaH425 plaque 2
Translation of DeltaH425 plaque 3
Translation of DeltaH425 plaque 4
Translation of DeltaH425 plaque 5
Translation of DeltaH425 plaque 6
Translation of DeltaH425 plaque 7
Translation of DeltaH425 plaque 8
Translation of DeltaH425 plaque 9
Translation of DeltaH425 plaque 10
Translation of Wt G

390
400
410
420
430
440
450
460
(376) 376
(80) FEHP-IQDAASQLPDDEILFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDEILFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDEILFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(80) FEHP-IQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE
(376) FEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTDIE

Translation of F440A/F441A plaque 1
Translation of F440A/F441A plaque 2
Translation of F440A/F441A plaque 3
Translation of F440A/F441A plaque 4
Translation of F440A/F441A plaque 5
Translation of F440A/F441A plaque 6
Translation of F440A/F441A plaque 7
Translation of F440A/F441A plaque 8
Translation of F440A/F441A plaque 9
Translation of F440A/F441A plaque 10
Translation of Wt G

390
400
410
420
430
440
458
(376) 376
(80) FEHPHIQDAASQLPDDESLVAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDESLTAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDESLAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIK-KHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEILAAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(80) FEHPHIQDAASQLPDDEXLVAGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD
(376) FEHPHIQDAASQLPDDESLFFGDTGLSKNPIELVEGWFSSWKSSIASFFFIIGLIIGLFLVLRVGIHLCIKLKHTKKRQIYTD

Figure 4-2. Sequence alignments of plaque isolates. Unpassaged supernatants from a
recovery of rVSV encoding G containing ΔH425 and F440A/F441A, respectively, were
titered using a standard plaque assay. Approximately 24 hrs post infection 10 plaques
from each plaque assay were removed using a Pasteur pipette, resuspended in DMEM
containing 5% FBS and the eluted virus (plaque isolate) was used to infect BHK cells.
RNA was extracted from the cells, reverse transcribed, the membrane-proximal region,
transmembrane, and cytoplasmic tail were PCR amplified and the resulting cDNA was
used for sequencing
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Figure 4-3. Plaque sizes. Representative plaques are shown from plaque assays in
which the cells were infected with viruses containing G mutations as indicated. Three
separate experiments were done with wild type controls from each experiment shown.
Approximately 36 hrs post infection plaques were stained with I1 monoclonal antibody
followed by a fluorescently conjugated secondary antibody.
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specific monoclonal antibody, I1, followed by a fluorescently conjugated secondary
antibody. Three panels showing wild type VSV plaques are shown. Three separate
experiments were done so the three wild type panels the positive control for each
experiment. The sizes of the wild type plaques vary in part due to the confluency of the
cells that are infected. If a plate is less confluent, a larger plaque would likely be
observed whereas when the cells are highly confluent and touching one another the
plaques generally appear smaller. Similar amounts of cells were used each of the plates
for an experiment (but may vary between experiments). The plaque sizes of the
F440T/F441A, F440A/F441A/CT9, F440V/F441A, and ΔH425 mutant virus infections
were greatly reduced in size from the wild type control. Interestingly, F440A/F441A/
S438I, ΔH425/I426S/S438I, and ΔH425/S438I plaques were all near the same size as
wild type plaques. Since the mutations arose upon passaging the virus very few times we
could not be sure that during these experiments further mutations were not arising.
Therefore, the rest of the characterization of these mutants will be done using cells
transiently expressing the protein instead of virus infection.
Surface Expression in Transiently Transfected Cells. The first step in identification of
possible advantages variants may have gained, enabling outgrowth of the mutant parent
virus, was to examine the surface expression of these mutant G proteins using transient
transfection assays. First, the mutant G proteins were sub-cloned into pCAAGS-GIND
expression vectors. This was done by extracting viral RNA from infected cells, reverse
transcription, and then the region containing the mutations was amplified using MW36
and 3464 (as previously described). The amplicon was digested with KpnI and NheI
restriction enzymes and subcloned into a pCAGGS-GIND plasmid digested with the same
enzymes. The plasmids were sequenced to ensure no unexpected mutations arose during
PCR amplification.
Since the original constructed mutations resulted in a reduced level of surface
expression (Fig 3-2), I wanted to determine if the additional mutations arose to
compensate for the reduced cell surface expression. All of the mutants were expressed as
well or better than wild type GIND with the exception of the F440A/F441A/CT9 mutant,
which was expressed less than 20% that of wild type (Fig 4-4). This result was not
surprising since previous studies with a mutant G protein containing only 9 residues in
the C-tail showed cell surface expression levels approximately 38% that of wild type G
(Whitt et al 1989). These results indicated that the additional mutations that arose, with
the exception of F440A/F441A/CT9, enhanced surface expression of the mutated G
proteins.
Cell-Cell Fusion in Transiently Transfected Cells. The next step in potentially
understanding the means by which the mutations acquired during passaging of the virus
overcame growth defects was to examine cell-cell fusion capacity. A syncytium
formation assay was used to compare the cell-cell fusion activity of the mutants with that
of wild type G. Since the cell-cell fusion assays in BHK-21 cells transiently expressing
G proteins containing F440A/F441A and ΔH425 mutations indicated the threshold pH for
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Figure 4-4. Surface expression in transiently transfected cells. Surface expression
was measured by flow cytometry of cells transiently transfected with plasmids encoding
the appropriate G mutant. Cells were fixed approximately 24 hours post transfection and
stained using I1 G monoclonal antibody and a secondary antibody conjugated to FITC.
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fusion was reduced to below 6.0, I wanted to see if the additional mutations were able to
overcome this shift. To ensure that the mutated G proteins were expressed at levels
greater than or equal to that of wild type G protein, I transfected cells using less plasmid
cDNA encoding wild type than the mutant G proteins (2/5 the amount of Wt G as mutant
G cDNA). The F440A/F441A/CT9 mutant was still greatly reduced as compared to wild
type G. Unexpectedly, the ΔH425/S438I mutant was also expressed only about 50% that
of wild type. However, regardless of the reduced level of surface expression, significant
cell-cell fusion could still be observed at pH 5.2 as well as pH 6.0 (Fig 4-5 and 4-6A).
F440V/F441A and F440T/F441A both showed no cell-cell fusion at pH 6.0, but when
treated at pH 5.2, a high level of fusion was then observed. Interestingly, the ΔH425
mutants initially showed a decrease in the pH threshold for fusion, but when ΔH425
acquired the S438I mutation or both S438I and I426S mutations, fusion was induced at
pH 6.0 (Fig 4-5 and 4-6A). These data suggest the S438I mutation helps to overcome the
requirement for a lower pH for fusion that results from either the ΔH425 or
F441A/F441A mutations.
Discussion
Vesicular stomatitis virus has widely been used to study viral evolution due to the
rapid rate at which the virus acquires mutations during replication. RNA viruses have a
very high mutation rate that is attributed to the error prone RNA dependent RNA
polymerase. The mutation rates in RNA viruses have been found to be one mutation per
genome per round of replication (Drake 1999). Since mutations are constantly arising,
RNA virus populations are very heterogeneous. This heterogeneity among the viral
populations (in particular RNA viruses) is referred to as “quasispecies”. A rapid rate of
mutation among RNA viruses likely enables the viruses to become more fit for infection
in a constantly changing environment.
Studies have been aimed at determining the ability viruses to express foreign
genes though multiple rounds of infection without mutations arising. VSV has served as
an attractive candidate for gene therapy and therefore examining the rate of mutation in
this virus has proven important. One such study identified the number of passages on
cells in which VSV encoding CD4 could maintain CD4 expression without mutations
arising within this gene. Experiments indicated that VSV expressing CD4 remained
stable for 26 passages before a mutation arose that affected expression of the foreign gene
(Quinones-Kochs, Schnell et al. 2001). Viruses that were more fit for infection (did not
have the foreign gene expressed) outgrew the CD4 expressing population. However
when VSV expressed the measles virus F protein in addition to the G protein, the virus
showed a loss of F protein expression after the first passage. The authors hypothesized
that the F protein affected some aspect of VSV growth and therefore the virus that was
more fit for infection became predominant in the population (Schnell, Buonocore et al.
1996; Quinones-Kochs, Schnell et al. 2001).

64

Figure 4-5. Cell-cell fusion activity. 6 cm plates of BHK-21 cells were transfected
using 2µg of plasmid DNA encoding wild type GIND or 6µg of plasmid DNA encoding
each of the mutated G proteins. 2 hours post transfection the cells were trypsinized and
plated onto 4 x 35 mm plates. Approximately 24 hours post transfection the cells were
rinsed one time and incubated in fusion media buffered to pH 7.0, 6.0, or 5.2 for 1 min at
room temperature. The media was then replaced with DMEM containing 5% FBS for 30
minutes. The cells were then photographed using a Zeiss Axiophot camera and Axiophot
software.
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pH 5.2

Figure 4-6. Quantitation of cell-cell fusion activity. (A) Cell-cell fusion activity was
measured from the experiment in figure 4-5 by counting cells that had not fused in three
separate fields of view per plate. Percentages were calculated based on the number of
cells fused (in three separate fields of view) as compared with plates treated at neutral pH
(7.0) and normalized to wild type by calculating percent fusion observed. (B) One of the
plates from the transfection described in fig 4-5 was used to measure surface expression
at ~ 24 hrs post transfection. Relative surface expression as a percentage of wild type as
described in figure 3-5 is shown.
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Chapter 3 was aimed at understanding the role of the membrane-proximal region
of VSV G through the use of a mutational analysis. Two mutant viruses were recovered
that upon passaging on BHK-21 cells began growing to significantly higher titers and
forming larger plaques than what was seen from the original recovery supernatant. The
G proteins expressed on these viruses acquired additional mutations from those originally
constructed. Since mutations rapidly arose in these viruses I wanted to determine what
enabled the viruses to grow and spread more readily than the original mutants (ΔH425
and F440A/F441A). Both ΔH425 and F440A/F441A were reduced in cell surface
expression and had a lower pH threshold for fusion (Fig 3-2, 3-4, 3-5) and therefore, I
hypothesized that the additional mutations enabled the virus to overcome these defects,
allowing for more efficient growth and spread.
Through the use of a standard plaque assay we were able to identify a number of
other mutants within the recovery supernatant. We chose to use these mutants as tools to
attempt to understand the importance of the F440, F441, and H426 residues and possibly
identify other residues that participate in membrane fusion or play a role in efficient
growth and spread of the virus. The mutant viruses that we observed in the respective
recovery supernatants were ΔH425, ΔH425/S438I (also obtained from passage P5,
ΔH425/I426S/S438I), F440V/F441A, F440T/F441A, F440A/F441A/CT9, and
F440A/F440A/S438I. Interestingly, the S438I mutation was observed in both the ΔH425
and F440A/F441A recovery supernatants indicating that mutation of this residue alone
likely helps in overcoming the defects that cause the virus to be less infectious. Also,
notably, we did not identify any virus with only the F440A/F441A mutation, which may
indicate that these two residues are very important in producing infectious virus.
Likewise, additional mutations only arose at position F440 but not F441 possibly
suggesting this residue is more critical to successful infection. Experiments using cells
transiently expressing the mutant G proteins were employed to address the role of H425,
F440, and F441 since mutations arise so rapidly in the context of a viral infection.
Further experiments in this chapter revealed that the additional mutations, with
the exception of F440A/F441A/CT9, enhanced the cell surface expression of the mutated
G proteins to near wild type levels. Interestingly, previous studies pertaining to the role
of the C-tail of VSV G in virus assembly examined truncation mutants in which one of
those mutants was a G protein with a truncated C-tail of only 9 amino acids (CT9) (Whitt
1989). This mutant was also expressed on the surface at significantly reduced levels.
Infectivity was measured by the ability of the mutant G protein to rescue infectivity of the
tsO45 mutant that was described in chapter 1. A 10-fold reduction in titer was observed
when the CT9 mutant was used to rescue infectivity of tsO45 as opposed to wild type
GIND. The authors conclude that the reduction in surface expression accounts for the
reduction in viral titer (Whitt, Chong et al. 1989). The next step in characterization of
these mutants was to examine fusion capacity.
Cell-cell fusion experiments revealed that the membrane fusion activity of the
ΔH425/S438I and ΔH425/I426S/S438I was restored to near wild type levels at both pH
6.0 and 5.2. Interestingly, in this experiment, the ΔH425/S438I mutant was only
expressed at approximately 60% that of wild type and still was able to fuse at a level
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similar to that of wild type. This finding suggests the level of surface expression is not
the primary determinant for efficient fusion of these mutated G proteins. Alternately, the
mutation may have produced a G protein that is a hyperfuser and therefore able to
overcome reduced surface expression levels by fusing with greater efficiency. Likewise,
the finding may also indicate a level of expression that is sufficient to drive near wild
type levels of fusion. Further examination of levels of expression in correlation to fusion
activity of G protein would be necessary to address these possibilities. The
F440A/F441A/S438I mutant also showed a restoration in fusion at pH 6.0. The S438I
mutation appears to enable the virus to overcome the decrease in threshold pH required
for fusion to occur. Perhaps the added hydrophbicity of the isoleucine at this position
allows for interaction with either the target membrane or the viral membrane during the
fusion process, causing destabilization of the membrane and promoting membrane fusion.
Cell-cell fusion activity at pH 6.0 was not observed to be restored in the other
mutants examined; F440V/F441A, F440T/F441A, or F440A/F441A/CT9. Since these
viruses likely outgrew the F440A/F441A mutant virus, some added benefit appears to
have arisen with the additional mutations. Phenyalanine residues are able to interact with
other aromatic amino acids containing free pi electrons. The two phenylalanines at
positions 440 and 441 could have formed interactions with other aromatic residues that
are nearby in the post fusion structure for stabilization. Without these phenylalanines, the
protein may rely on other interactions to provide stability which allows for more efficient
fusion. Perhaps the alanines mutate to valine or threonine respectively due to the larger
size of these residues which in turn positions other residues within the protein in close
proximity for interactions. Further studies would be helpful in addressing theses
possibilities.
Surprisingly, F440A/F441A/CT9 was not enhanced in either cell surface
expression or cell-cell fusion capacity. The cytoplasmic domain of viral fusion proteins
such as Alphaviruses (Zhao, Lindqvist et al. 1994) and Retroviruses (Cosson 1996) have
been shown to be important factors in the efficient budding of progeny virus. Since
previous studies examining the length requirement for the C-terminus of VSV G
indicated at least 9 residues are required for the efficient incorporation of G into virions
(Whitt, Chong et al. 1989) the CT9 mutant should be incorporated efficiently. The
question as to the advantage this rapidly acquired mutation provides still remains. One
possibility is the shorter C-tail is better positioned to interact with the cell membrane
which in effect aids in the membrane curvature required for budding of progeny virus.
However, one would expect to have seen an enhancement in virus budding in the
previous study using a CT9 mutant, so this is likely not the case. Further experimentation
would be needed to identify the advantage gained by acquiring the CT9 mutation in the
F440A/F441A encoding virus.
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Chapter 5: General Discussion
Involvement of G Protein in VSV Infection
Vesicular stomatitis virus is an enveloped virus that must undergo a fusion event
mediated by the outer surface protein, G, to gain access into a host cell. Viral fusion in
enveloped viruses has been widely studied, with Influenza HA being the first fusion
protein to be extensively characterized (Wiley, Wilson et al. 1981; Wilson, Skehel et al.
1981). Viral fusion proteins are required for entry into the host cell and function by
mediating the membrane merger event between the viral membrane and the host cell
membrane. Crystal structure data for fusion proteins has provided much insight as to
mechanisms by which these proteins may mediate viral entry, a critical step in the life
cycle of the virus. However, since no crystal structure data is available for the
membrane-proximal region of these proteins, little is understood in regard to the exact
role of this region in membrane fusion. Previous mutational analyses of VSV G have
suggested a direct contribution of the membrane-proximal region of the protein to the
fusion and budding processes (Robison and Whitt 2000; Jeetendra, Robison et al. 2002;
Jeetendra, Ghosh et al. 2003). I am proposing a model for the contribution of the
membrane-proximal region of G in host cell entry of VSV.
VSV G Mediated Entry. Vesicular stomatitis virus enters host cells through receptormediated endocytosis (Matlin, Reggio et al. 1982). The glycoprotein, G, on the outer
membrane of the virus binds the host cell through an unknown receptor (Coil and Miller
2004), is endocytosed by clathrin coated vesicles and transported through the endocytic
pathway (Matlin, Reggio et al. 1982). Evidence from our lab (Mire 2008), as well as
others, suggests the fusion event occurs within the acidic environment of the early
endosomes while another group argues transport to late endosomes is required (Le Blanc,
Luyet et al. 2005). Upon acidification of the endosome, a reversible conformational
change in the G protein is triggered. The reversible nature of this conformational change
is a unique feature of the G protein that has not been observed in other viral fusion
proteins (Roche and Gaudin 2002). Once the initial conformational changes occur, the
fusion peptide is thought to insert into the target membrane allowing for further
conformational changes that pull the two membranes together. A fusion pore is formed
and the viral ribonucleocapsid is released into the host cell cytosol where replication
takes place. The solution of G protein crystal structures of G in both pre- and post fusion
forms (Roche, Bressanelli et al. 2006; Roche, Rey et al. 2007) resulted in the
classification of a third group of fusion proteins. Fusion proteins that do not fit into class
I or class II but have structural homology to VSV G in the post fusion structure are
grouped into this class, as well. Further elucidation of the VSV G-mediated fusion
mechanism hopefully will provide clues as to the entry processes of less understood
viruses.
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Prototypic Class III Fusion Protein. The past few years have provided a wealth of
groundbreaking research contributing greatly to our understanding of viral fusion. As
mentioned, a new class of fusion proteins (class III) has been identified based on
determination of the crystal structures of G in the pre- and postfusion forms (Roche, Rey
et al. 2007) and their homology to the postfusion form of Herpes virus gB (Heldwein,
Lou et al. 2006). More recently, the Baculovirus gp64 (Kadlec, Loureiro et al. 2008) and
Epstein-Barr virus gB postfusion structures have been solved (Backovic, Longnecker et
al. 2009) revealing similar postfusion structures to that of VSV G and therefore are
grouped in this class. Since VSV G is the only protein in this new group of fusion
proteins in which both the pre and postfusion crystal structures have been solved, it
serves as the prototype. However, we still have a number of gaps in understanding the
exact pathway of VSV G mediated membrane fusion. Intermediate structures of G
protein in the transition from the pre-fusion to the postfusion state have yet to be
identified and structural information is not available for the membrane-proximal region,
leaving many unanswered questions. We are uncertain as to the exact contribution of the
membrane-proximal region in achieving the structural transitions leading to membrane
fusion or perhaps even in the actual membrane merger event itself. In an effort to further
elucidate the membrane fusion pathway of VSV G, the prototypic class III fusion protein,
I chose to employ a mutagenesis approach focusing on the membrane-proximal region to
identify the possible role of specific residues within this highly conserved region.
VSV G Mediated Membrane Fusion Model
Based on the available structural data and our recent findings, we have developed
a model for the events leading to VSV G mediated membrane fusion (Fig 5-1). VSV G
trimers are embedded in the envelope of the virus and thought to sit on the surface of the
virion forming “tripods” (Roche, Bressanelli et al. 2006) (Step 1). The fusion domains
serve as legs of the tripod with the membrane proximal regions positioned on the interior.
The first step in G mediated membrane fusion is likely the binding of G to a phospholipid
or other ubiquitious molecule on the cell surface (Schlegel, Willingham et al. 1982;
Carneiro, Bianconi et al. 2002; Coil and Miller 2004). Once bound to the cell surface the
virus is internalized via receptor mediated endocytosis (Matlin, Reggio et al. 1982). At
this stage in the fusion pathway G is likely still in the prefusion conformation that is
believed to be stabilized by noncovalent interactions between the fusion domain and the
membrane-proximal region (Roche, Bressanelli et al. 2006). As the pH decreases within
the endosome a conformational change occurs in G that exposes the bipartite fusion
loops, enabling them to be inserted into the target membrane (Step 2).
The next step is the clustering of G trimers at the fusion site. Previous reports in
rabies virus indicate a requirement of 13 to 19 G trimers for membrane fusion (Gaudin,
Tuffereau et al. 1991). The sequestering of a number of fusion proteins is seen in other
viruses such as SFV E1, which has been shown to form rings of 5 to 6 trimers (Gibbons,
Reilly et al. 2004; Kielian and Rey 2006). Similarly, a need for clustering of fusion
protein trimers has been observed in TBE E (Stiasny, Kiermayr et al. 2006). When only
the C-tail, transmembrane domain, and membrane-proximal region of G are expressed,
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Figure 5-1. Model for VSV G mediated membrane fusion. (Step 1) G trimers sit on
the virion surface like “tripods”. This model shows the fusion domains (blue) on the
interior of the trimer and extending downward toward the virion membrane. The Cterminal domain is extending out of the virion envelope and likely forming interactions
with the fusion domain to stabilize the prefusion structure. (Step 2) Once exposed to the
low pH environment of the endosome a conformational change occurs releasing the
fusion peptide and allowing for insertion into the target membrane. (Step 3) G trimers
cluster at the fusion site possibly through lateral interactions of the membrane-proximal
domain. (Step 4) As the pH decreases in the endosome further conformational changes
occur that pulls the two membranes together, forming a hemifusion intermediate. (Step
5) Protonation of specific histidine residues leading to the formation of salt bridges with
acidic residues in close proximity “lock” the low pH structure in place, allowing for
fusion pore formation.
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the truncated mutant is able to form trimers on the virion surface (Robison and Whitt
2000). The ability of this mutant to form trimers indicates that the residues within the
truncated ectodomain can likely form interactions. Based on these findings, one
hypothesis for a role of the membrane-proximal region of G is to recruit enough G
trimers to the fusion site to allow for fusion. At this stage, the fusion protein is forming a
“pre-hairpin intermediate” and is in an extended structure. The conformation of G then
changes from the extended state that allows for insertion into the target membrane by
folding back on itself, bringing the C-terminal end and the fusion domain together. The
dramatic conformational change pulls the two opposing membranes into close proximity
causing the initial lipid mixing, or hemifusion (step 3).
Histidine protonation has been suggested to drive this low pH-induced structural
transition (Carneiro, Stauffer et al. 2003). Upon protonation of specific histidine
residues, initial interactions are released, exposing the fusion loops. The protein then
folds back on itself and the newly protonated histidines come into proximity with acidic
residues in which they can form salt bridges. Formation of these interactions stabilizes
this “hairpin” structure so that the highly unfavorable event, membrane merger, can occur
(step 5). Histidine has a pKa of 6 indicating that when G is exposed to low pH this
residue becomes protonated (Carneiro, Stauffer et al. 2003). The small pH range
required for the conformational changes to occur suggests the protonation of only a few
ionizable groups is required for the structural changes to occur in G. I hypothesize that G
undergoes the initial conformational changes driven by protonation of histidine residues,
such as H148 and H149, (Carneiro, Stauffer et al. 2003) but that protonation of H423
perhaps “locks” this postfusion conformation long enough to allow for outer lipid mixing,
then pore formation, leading to release of the nucleocapsid into the host cell cytoplasm.
When H423 is deleted (in the mutant ΔH423/P424/H425) no cell-cell fusion is observed.
The mutated protein is still observed to undergo pH dependent conformational changes
suggesting the residue is not critical for the low pH induced changes, but perhaps for
maintaining the stability of the low pH form. The DDE motif examined in chapter 3
could possibly serve to interact with the newly protonated histidine residues to “lock” the
protein in the post-fusion structure. The last step in the fusion process is the complete
mixing of the inner and outer leaflets of the two membranes and formation of a fusion
pore in which the viral RNP can pass through for release into the host cell cytoplasm.
Rapid Acquisition of Growth Enhancing Mutations
RNA viruses have a very rapid mutation rate due to the error prone RNA
dependent RNA polymerase used for replication. This high rate of mutation likely
enables the virus to adapt to a constantly changing environment. Vesicular stomatitis
virus serves as an attractive candidate for gene therapy and therefore examination of the
rate of mutation has been widely studied. Our findings suggest mutations made to the
membrane-proximal region of the virus, producing less infectious virus, are rapidly
compensated for through the incorporation of additional mutations. Some of these
rapidly acquired mutations appeared to overcome the fusion defect of the original desired
mutation (F440A/F441A/S438I, ΔH425/S438I, and ΔH425/I426S/S438I). However,
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other mutations arose that showed the same fusion phenotype as was observed for the
original intended mutant (F440V/F441A, F440A/F441A/CT9, and F440T/F441A).
These data indicate that the mutations made to the membrane-proximal region of the G
protein affected another stage of the viral life cycle. The viruses with the same fusion
defect as the F440A/F441A mutants were able to outgrow their respective parent virus
indicating the mutation still provided some benefit, at a stage after the fusion event that
enabled the virus to be more infectious. The original constructed mutation resulted in a
decrease in the threshold pH required to trigger fusion between the virus membrane and
the host cell endosomal membrane. Previous work in our lab has shown that mutations
made to G protein causing a reduction in the pH at which fusion occurs resulted in
production of less infectious virus (Fredericksen and Whitt 1995). The likely reason for
the decrease in viral titers observed for those viruses expressing mutated G proteins with
a reduced pH threshold for fusion is the release of the RNP at a later time point in the
endocytic pathway. As the virus traverses the endocytic pathway, the pH drops. When
the pH reaches between 6.2 and 6.3 the viral membrane undergoes a fusion event with the
host cell endosomal membrane, releasing the viral genetic information in to the cell
cytoplasm where replication takes place. A G protein with mutations resulting in the
requirement of a lower pH for fusion would cause the RNP to be released at a different
point within the endocytic pathway. The fusion defect could possibly thereby have
resulted in a replication, assembly, or budding defect. The additional mutations that
arose could compensate for the fusion defect as was observed for the mutants that
acquired the S428I mutation. However, the F440V/F441A and F440T/F441A mutants
did not have restoration of fusion at the optimal pH for wild type G protein. These
viruses outgrew the F440A/F441A mutant virus indicating the viruses may have mutated
to overcome the possible replication, assembly, or budding defect that resulted from the
decrease in the pH required for fusion. The rapid rate in which the additional mutations
arise confirms our hypothesis that the membrane-proximal residues are critical to
membrane fusion and infectivity of VSV.
Role of GS in VSV Infection
Studies involving GS have shown that this truncated G protein is present on the
wild type VSV virion and can form trimers (Metsikko and Simons 1986; Robison and
Whitt 2000). GS, when expressed independently, can bind host cells, induce hemifusion,
and potentiate cell-cell fusion when co-expressed with a fusion protein that cannot
mediate fusion on its own (Robison and Whitt 2000). Due to the interesting
characteristics of this truncated G protein, questions have arisen in regard to its
contribution to infection (if any). The mutational analysis conducted in chapter 3
revealed a G protein that, when D437, D438, and E439 are mutated to alanines, results in
a reduction in cell-cell fusion activity. This phenotype, however, did not correlate with
what was seen in the virus. The recombinant virus encoding this mutant G protein grew
to titers similar to that of wild type and formed large plaques when examined by standard
plaque assays. Immunoblots of purified virus revealed a significantly larger amount of a
C-tail antibody reactive protein which, based on its size, represents GS, than what was
seen in wild type VSV. We were unable to successfully immunoblot transiently
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transfected cells to determine if G is being cleaved in the context of a viral infection or if
this same cleavage product can be detected in the transiently transfected cells. One
possible explanation for the disconnect in data between the fusion assays performed on
transiently transfected cells and the ability of the virus to grow and spread is the ability of
GS to potentiate the fusion of viral fusion proteins that cannot fuse independently.
Previous reports proposed a model, based on the ability of GS to bind cells, form trimers,
and induce hemifusion, suggesting that GS interacts with the target membrane causing
destabilization (Jeetendra, Robison et al. 2002).
A cleavage site for G, producing GS, has yet to be identified. Therefore, it is not
known at what location in the cell G protein is truncated. Many viral fusion proteins are
proteolytically cleaved during transport through the secretory pathway by furin. Furin is
a calcium dependent serine endoprotease that cleaves just downstream of Arg – X(Lys/Arg) – Arg and is enriched in the Golgi. If the DDE mutant G protein is being
cleaved by furin resulting in enhanced GS production, the truncated protein likely would
be observed in the transiently expressing cells since the furin cleavage occurs in the
secretory pathway. Therefore, any affect on fusion capacity would likely be observed in
cells transiently expressing the mutant G protein. Another possibility could be cleavage
occurring by enzymes within the acidic envoironment of the endosomes. Since the DDE
mutant has a reduced pH threshold for fusion the virus would travel further on the
endocytic pathway. The mutated G protein could be exposed to enzymes within the late
endosomes/lysosomes that cleave G forming GS. This theory could explain the
disconnect in data between cell-cell fusion assays using transiently transfected cells
versus those infected with recombinant virus. Regardless of the means by which G is
cleaved, the experiments in chapter 3 suggest that the increased level of GS on the virion
surface helps the virus overcome the fusion defect resultant from the
D435A/D436A/E437A mutation. We developed a model suggesting how the GS protein
could aid in the VSV G mediated fusion process.
Figure 5-2 depicts how GS could enhance fusion/entry of VSV G by either
binding to and destabilizing the target membrane on the outside of the trimers (Fig 5-2A),
or interacting with the viral membrane to cause destabilization (Fig 5-2B). Alternatively,
GS could be positioned on the inside of the “tripod” and as the membranes are being
pulled together the truncated protein could interact with the target membrane causing
destabilization and in effect help in the membrane merger event (Fig 5-2C). However,
our data merely suggests this possibility and further studies would need to be done to
draw further conclusions.
Future Experiments
To further examine steps in the VSV G mediated vius-cell membrane fusion
pathway it would be helpful to identify structural intermediates in the transition from the
prefusion form to the low pH conformation. Identification of these intermediates could
give further insight as to the contribution of the membrane proximal region.
Determination of these intermediates in the structural rearrangements that lead to fusion
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Figure 5-2. Potential role of GS in VSV G mediated fusion. VSV G trimers are
initially present on the virion surface as “tripods” in their prefusion form. Upon exposure
to low pH, G undergoes a reversible conformational change that initially exposes the
fusion peptide and allows for insertion into the target membrane. (A) Once the fusion
peptide has inserted into the target membrane it “folds back” on itself pulling the two
opposing membranes together. One potential role of GS (shown in red) in VSV G
mediated fusion is destabilization of the target membrane when the two membranes are
initially being pulled together. (B) Alternately, GS could lay parallel to the virion
membrane and interact with the viral envelope to enhance the membrane fusion activity
of G. (C) GS could also participate by destabilizing the target membrane at the site
where the two opposing membranes are being pulled together.
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could also provide clues as to the pathway of the other newly characterized class III
fusion proteins such as Herpes virus gB, Baculovirus gp64, and Epstein-Barr virus gB.
A challenge in studying the transition from the pre- to postfusion conformational change
in the G protein is the inability to detect intermediates with antibodies (as is seen in SFV
E1, for example) Previous attempts at generating monoclonal antibodies to the membrane
proximal region of G have been unsuccessful (personal communication with Mike
Whitt). Perhaps peptide inhibitors could be designed directed toward the membrane
proximal region to determine if structural transitions could be blocked by the interference
of the peptides, as seen with PIV-5 F (Russell, Jardetzky et al. 2001).
Data in chapter 3 suggests a critical role of the conserved HPH motif (or just the
histidines). An experiment that would help examine the hypothesis that these histidines
are involved in stabilization of the post fusion structure would be to do a 3-color fusion
assay with ΔH423/P424/H425 (fusion defective) to detect if this fusion defective mutant
is able to achieve hemifusion. If this mutant were able to achieve hemifusion it would
support the idea that the histidines or the HPH motif is important to stabilization of the
final, low pH conformation. Initial conformational changes would allow for insertion of
the fusion peptide, further conformational changes would allow for hemifusion to be
observed, however if the structure is not stabilized full fusion would not occur (as was
observed in chapter 3). Since I propose the mutated residues in chapter 3 are important to
the low pH-induced conformational changes it would be helpful to do a trypsinsensitivity assay in which limiting amounts of trypsin is used to look at the stability of the
conformational changes.
I also think that additional mutations in the membrane proximal region could
provide more conclusive evidence regarding specific residues in this region. For
example, H423 (the histidine proposed to form a salt bridge with D137) should be
mutated to determine if this one histidine residue is critical to G-mediated membrane
fusion. Likewise, my model for VSV G mediated membrane fusion suggests the possible
role of hydrophobic residues. Further mutational analysis in which hydrophobic residues,
such as F421, I426, L433, L439, and L446 are changed to alanines to identify if the
hydrophobicity of this region plays a role in the virus-cell fusion pathway of G.
Furthermore, it would be interesting to mutate the serine at position 438 (that was
mutated to an isoleucine in several of the variants) to an isoleucine to see if an enhanced
fusion or cell surface expression phenotype could be observed to explore the advantage
of the amino acid change to virus entry. The mutants from chapter 3 should also be
examined for their budding capacity at early time points and experiments should be done
to measure the replication capacity (real time PCR could be used to measure this).
The D435A/D436A/D437A mutant provides the first possible evidence for a role
for GS in the context of its natural expression on the virion surface. However, the data
(in chapter 3) only suggests the possibility that GS functions to enhance fusion activity
(possibly even more when environmental pressures are limiting the ability of the virus to
grow and spread efficiently). Unfortunately, experiments in which detection of GS in
cells transiently transfected with either wild type G or D435A/D436A/E437A were
unsuccessful, leaving doubt as to the level of cleaved G (GS) on the cell surface in the
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context of transient expression. Optimization of this experiment should be explored by
immunoprecipitating the protein from overexpressing cells. One problem in the
experiment has been the amount of protein is very small making detection challenging.
Likewise, when the experiment is done on cell lysates that have not been
immunoprecipitated non-specific interactions are detected preventing visualization of GS.
An experiment that would help determine the proximity of GS on the virion (or
cell) surface is the use of electonmicroscopy with immunogold labeling This suggestion
is based on experiments done by Dr. Doug Lyles (Wake Forest University) that identified
the localization of G in microdomains on the virion surface (Brown and Lyles 2003).
This experiment would answer the question as to whether G and GS are even located in
the same microdomains to determine if both proteins are even present at the fusion site
simultaneously.
In conclusion, these studies have given further insight to the VSV G mediated
membrane fusion pathway by identifying residues within the membrane-proximal region
of which no structural information is available. Gaining a better understanding of the Gmediated fusion event also can give provide clues as to the mechanisms other class III
fusion proteins utilize, in particular human pathogens such as herpes simplex EpsteinBarr viruses.
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